FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lars Klareskog

Research Profile

Disorders

Chemicals & Drugs

Geographic Areas

Sweden

Procedures

Case Control Studies

Anatomy

Physiology

Living Beings

Rats

Co-author Network

Publications

TOP 3
Emeli Lundström; Gunnel Nordmark; Leonid Padyukov; Lars Rönnblom; Johanna K Sandling; Gunnar Sturfelt; Ulf Sundin; Anders A Bengtsson; Kerstin Elvin; Iva Gunnarsson; Johanna T Gustafsson; Andreas Jönsen; Henrik Källberg; Lars Klareskog; Dag Leonard; Ann-Christine Syvänen; Agneta Zickert; Elisabet Svenungsson
HLA-DRB1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus.
Jaime E Hart; Marie Holmqvist; Henrik Källberg; Lars Alfredsson; Tom Bellander; Karen H Costenbader; Lars Klareskog; Andrea Abu-Akel; Elizabeth W Karlson
Ambient air pollution exposures and risk of rheumatoid arthritis: results from the Swedish EIRA case-control study.
Karin Lundberg; Leonid Padyukov; Iskra Pollak-Dorocic; Evan Reed; Lars Alfredsson; Camilla Bengtsson; Rikard Holmdahl; Lena Israelsson; Xia Jiang; Henrik Kallberg; Christoph Kessel; Nastya Kharlamova; Lars Klareskog
Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lars Klareskog (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Emeli Lundström; Gunnel Nordmark; Leonid Padyukov; Lars Rönnblom; Johanna K Sandling; Gunnar Sturfelt; Ulf Sundin; Anders A Bengtsson; Kerstin Elvin; Iva Gunnarsson; Johanna T Gustafsson; Andreas Jönsen; Henrik Källberg; Lars Klareskog; Dag Leonard; Ann-Christine Syvänen; Agneta Zickert; Elisabet Svenungsson
HLA-DRB1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus.
Annals of the rheumatic diseases 2013;72(6):1018-25.
2013: Jaime E Hart; Marie Holmqvist; Henrik Källberg; Lars Alfredsson; Tom Bellander; Karen H Costenbader; Lars Klareskog; Andrea Abu-Akel; Elizabeth W Karlson
Ambient air pollution exposures and risk of rheumatoid arthritis: results from the Swedish EIRA case-control study.
Annals of the rheumatic diseases 2013;72(6):888-94.
2013: Karin Lundberg; Leonid Padyukov; Iskra Pollak-Dorocic; Evan Reed; Lars Alfredsson; Camilla Bengtsson; Rikard Holmdahl; Lena Israelsson; Xia Jiang; Henrik Kallberg; Christoph Kessel; Nastya Kharlamova; Lars Klareskog
Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile.
Annals of the rheumatic diseases 2013;72(5):652-8.
2013: Robert M Plenge; Eli A Stahl; Anne Barton; S Louis Bridges; Marieke J H Coenen; Niek de Vries; Jonathan M J Derry; Stephen H Friend; Jeffrey D Greenberg; Peter K Gregersen; Henk-Jan Guchelaar; Tom W J Huizinga; Lars Klareskog; Lara M Mangravite; Xavier Mariette; Larry W Moreland; Leonid Padyukov; Gustavo Stolovitzky
Crowdsourcing genetic prediction of clinical utility in the Rheumatoid Arthritis Responder Challenge.
Nature genetics 2013;45(5):468-9.
2013: Mikael Brink; Göran Hallmans; Monika Hansson; Rikard Holmdahl; Per-Johan Jakobsson; Lars Klareskog; Linda Mathsson; Johan Rönnelid; Hans Stenlund; Solbritt Rantapää-Dahlqvist
Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis.
Arthritis and rheumatism 2013;65(4):899-910.
2013: Khaled Amara; Anca Irinel Catrina; Davide Corti; Marianne Engström; Blanca M Fernandez-Rodriguez; Lena Israelsson; Vijay Joshua; Lars Klareskog; Eric Meffre; Henner Morbach; Fiona Murray; Omri Snir; Johanna Steen; Hedda Wardemann; Vivianne Malmström
Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition.
The Journal of experimental medicine 2013;210(3):445-55.
2013: Yun Liu; Leonid Padyukov; Lovisa Reinius; Marcus Ronninger; Arni Runarsson; Annika Scheynius; Klementy Shchetynsky; Margaret Taub; Nathalie Acevedo; Lars Alfredsson; Martin Aryee; Tomas J Ekström; MARGARET D FALLIN; Espen Hesselberg; Juha Kere; Lars Klareskog; Andrew P Feinberg
Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis.
Nature biotechnology 2013;31(2):142-7.
2013: Patrik K E Magnusson; Anastasia Nyman; Nancy L Pedersen; Iffat Rahman; Maria Råstam; Fredrik Ullén; Alexander Viktorin; Hasse Walum; Catarina Almqvist; Henrik Anckarsäter; Sven Cnattingius; Ulf de Faire; Andrea Ganna; Clara H Gumpert; Linda Halldner; Erik Ingelsson; Magnus Johannesson; Lars Klareskog; Niklas Långström; Henrik Larsson; Sebastian Lundström; Paul Lichtenstein
The Swedish Twin Registry: establishment of a biobank and other recent developments.
Twin research and human genetics : the official journal of the International Society for Twin Studies 2013;16(1):317-29.
2013: Dorothée Diogo; Steve Eyre; Jason Flannick; Jeffrey D Greenberg; Peter K Gregersen; Candace Guiducci; Namrata Gupta; Brendan Hickey; Lars Klareskog; Joel M Kremer; Fina Kurreeman; Katherine P Liao; Javier Martin; Leonid Padyukov; Soumya Raychaudhuri; Stephan Ripke; Manuel A Rivas; Katherine A Siminovitch; Eli A Stahl; Shamil Sunyaev; Brian Thomson; Jane Worthington; Alexandra Zhernakova; Ivan Adzhubey; Lars Alfredsson; Anne Barton; John Bowes; Robert M Plenge
Rare, low-frequency, and common variants in the protein-coding sequence of biological candidate genes from GWASs contribute to risk of rheumatoid arthritis.
American journal of human genetics 2013;92(1):15-27.
2013: Imad Abugessaisa; David Gomez-Cabrero; Lars Klareskog; Staffan Lindblad; Vivianne Malmström; Omri Snir; Jesper Tegnér
Implementation of the CDC translational informatics platform - from genetic variants to the national Swedish Rheumatology Quality Register.
Journal of translational medicine 2013;11():85.
2013: Annmarie Wesley; Lars Alfredsson; Camilla Bengtsson; Ann-Charlotte Elkan; Lars Klareskog; Sara Wedrén
Association between body mass index and anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis: results from a population-based case-control study.
Arthritis care & research 2013;65(1):107-12.
2012: Maria Seddighzadeh; Lars Alfredsson; James D Clark; Bo Ding; Kyri Dunussi-Joannopoulos; Aida Ferreiro-Iglesias; Juan J Gomez-Reino; Antonio Gonzalez; Lars Klareskog; Leonid Padyukov
Variants within STAT genes reveal association with anticitrullinated protein antibody-negative rheumatoid arthritis in 2 European populations.
The Journal of rheumatology 2012;39(8):1509-16.
2012: Omri Snir; Ida Andersson; Johan Bäcklund; Julia Boström; Jane H Buckner; Rikard Holmdahl; Jan Kihlberg; Lars Klareskog; Vivianne Malmström
Multifunctional T cell reactivity with native and glycosylated type II collagen in rheumatoid arthritis.
Arthritis and rheumatism 2012;64(8):2482-8.
2012: Abqariyah Yahya; Amal Nasir Mustafa; Nor Aini Abdullah; Lars Alfredsson; Camilla Bengtsson; Heselynn Hussein; Lars Klareskog; Too Chun Lai; Per T Larsson; Norasiah Muhamad; Shahnaz Murad
Smoking is associated with an increased risk of developing ACPA-positive but not ACPA-negative rheumatoid arthritis in Asian populations: evidence from the Malaysian MyEIRA case-control study.
Modern rheumatology / the Japan Rheumatism Association 2012;22(4):524-31.
2012: Judit Laki; Emeli Lundström; Lars Alfredsson; Camilla Bengtsson; Anca I Catrina; Izabella Ganji; Lars Klareskog; Johan Rönnelid; Saedis Saevarsdottir; Omri Snir; MC Wick; Leonid Padyukov
Very high levels of anti-citrullinated protein antibodies are associated with HLA-DRB1*15 non-shared epitope allele in patients with rheumatoid arthritis.
Arthritis and rheumatism 2012;64(7):2078-84.
2012: Ulrike Harre; Per-Johan Jakobsson; Pierre Jurdic; Lars Klareskog; Grit Krumbholz; Elena Neumann; Falk Nimmerjahn; Elena Ossipova; Gabriella Sarmay; Hans-Ulrich Scherer; Roland Axmann; Holger Bang; Wolfgang Baum; Aline Bozec; Anca Irinel Catrina; Dan Georgess; Eszter Szarka; Rene Toes; Georg Schett
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin.
The Journal of clinical investigation 2012;122(5):1791-802.
2012: Danielle M Gerlag; Johanna M Hazes; Tom W J Huizinga; Lars Klareskog; Tore K Kvien; Cathryn Lewis; Klaus P Machold; Karim Raza; Johan Rönnelid; Georg Schett; Josef S Smolen; Elisabeth Brouwer; Christopher D Buckley; Gerd R Burmester; Anca I Catrina; Andrew P Cope; François Cornelis; Solbritt Rantapää Dahlqvist; Paul Emery; Stephen Eyre; Axel Finckh; Cem Gabay; Steffen Gay; Sue Thomas; Lisa G M van Baarsen; Annette van der Helm-van Mil; Jane Worthington; Dirkjan van Schaardenburg; Paul P Tak
EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis.
Annals of the rheumatic diseases 2012;71(5):638-41.
2012: Soumya Raychaudhuri; Cynthia Sandor; Katherine A Siminovitch; Eli A Stahl; Jane Worthington; Jan Freudenberg; Peter K Gregersen; Xiaoming Jia; Lars Klareskog; Hye-Soon Lee; Leonid Padyukov; Robert M Plenge; Lars Alfredsson; Sang-Cheol Bae; Paul I W de Bakker
Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis.
Nature genetics 2012;44(3):291-6.
2012: Anna Rudin; Thomas Skogh; Gunnar Sturfelt; Ronald van Vollenhoven; Hans Carlsten; Ingiäld Hafström; Lennart Jacobsson; Lars Klareskog; Ingrid Lundberg; Solbritt Rantapää-Dahlqvist; Lars Rönnblom; Tore Saxne
[Rheumatologic research with animal experiments is important for our patients].
Läkartidningen 2012;109(1-2):40.
2012: Mohammed Mullazehi; Ronald van Vollenhoven; MC Wick; Lars Klareskog; Johan Rönnelid
Anti-type II collagen antibodies are associated with early radiographic destruction in rheumatoid arthritis.
Arthritis research & therapy 2012;14(3):R100.
2012: CL Too; Abqariyah Yahya; Nor Aini Abdullah; Lars Alfredsson; Camilla Bengtsson; Jasbir Singh Dhaliwal; Lars Klareskog; Per Tobias Larsson; Nor Asiah Muhamad; Shahnaz Murad; Amal Nasir Mustafa; Leonid Padyukov
Smoking interacts with HLA-DRB1 shared epitope in the development of anti-citrullinated protein antibody-positive rheumatoid arthritis: results from the Malaysian Epidemiological Investigation of Rheumatoid Arthritis (MyEIRA).
Arthritis research & therapy 2012;14(2):R89.
2012: Berit M Sverdrup; Lars Alfredsson; Henrik Källberg; Lars Klareskog
Usage of skin care products and risk of rheumatoid arthritis: results from the Swedish EIRA study.
Arthritis research & therapy 2012;14(1):R41.
2011: Chris Cotsapas; Mark J Daly; Philip L De Jager; James T Elder; Robert R Graham; Peter Gregersen; David A Hafler; Lars Klareskog; Kasper Lage; Benjamin M Neale; Stephen S Rich; Elizabeth Rossin; Katherine A Siminovitch; John A Todd; David A van Heel; Benjamin F Voight; chris wallace; Cisca Wijmenga; Jane Worthington; Gonçalo R Abecasis; Jeffrey C Barrett; Timothy Behrens; Judy Cho
Pervasive sharing of genetic effects in autoimmune disease.
PLoS genetics 2011;7(8):e1002254.
2011: George Kollias; Iain McInnes; Piyi Papadaki; Ioannis Ragoussis; Georg Schett; Paul P Tak; Rene Toes; Wim van den Berg; Margriet J Vervoordeldonk; Wolfgang Wurst; Florence Apparailly; Vera Baumans; Christian Desaintes; James Di Santo; Jörg Distler; Paul Garside; Bert 't Hart; Martin Hegen; Rikard Holmdahl; Tom W J Huizinga; Astrid Jüngel; Lars Klareskog; Steffen Gay
Animal models for arthritis: innovative tools for prevention and treatment.
Annals of the rheumatic diseases 2011;70(8):1357-62.
2011: Martin Neovius; J F Simard; Johan Askling; Lars Klareskog
Sick leave and disability pension before and after initiation of antirheumatic therapies in clinical practice.
Annals of the rheumatic diseases 2011;70(8):1407-14.
2011: Marina Korotkova; Staffan Lindblad; Maria Seddighzadeh; Rene E M Toes; Lars Alfredsson; Anca Irinel Catrina; Nina A Daha; Bo Ding; Tom W J Huizinga; Per-Johan Jakobsson; Lars Klareskog; Leonid Padyukov
Variants of gene for microsomal prostaglandin E2 synthase show association with disease and severe inflammation in rheumatoid arthritis.
European journal of human genetics : EJHG 2011;19(8):908-14.
2011: Göran K Hansson; Lars Klareskog
Pulling down the plug on atherosclerosis: cooling down the inflammasome.
Nature medicine 2011;17(7):790-1.
2011: Bo Ding; Henrik Källberg; Lars Klareskog; Leonid Padyukov; Lars Alfredsson
GEIRA: gene-environment and gene-gene interaction research application.
European journal of epidemiology 2011;26(7):557-61.
2011: Eva Baecklund; Carin Backlin; Mahmoud Mansouri; Lars Klareskog; Johan Askling; Gunilla Enblad; Izidore S Lossos; Yasodha Natkunam; Anastasia Nyman Iliadou; Richard Rosenquist
LMO2 protein expression predicts survival in patients with rheumatoid arthritis and diffuse large B-cell lymphoma.
Leukemia & lymphoma 2011;52(6):1146-9.
2011: Lars Klareskog; Vivianne Malmström; Karin Lundberg; Leonid Padyukov; Lars Alfredsson
Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis.
Seminars in immunology 2011;23(2):92-8.
2011: Lars Klareskog; Markus Gaubitz; V Rodríguez-Valverde; Michel Malaise; Maxime Dougados; Joseph Wajdula
Assessment of long-term safety and efficacy of etanercept in a 5-year extension study in patients with rheumatoid arthritis.
Clinical and experimental rheumatology 2011;29(2):238-47.
2011: Jasper C A Broen; Marieke Coenen; Blanca Rueda; Torsten Witte; Leonid Padyukov; Lars Klareskog; Roger Hesselstrand; Dirk M Wuttge; Carmen Simeon; Norberto Ortego Centeno; Miguel A González-Gay; Anna Pros; Nicholas Hunzelman; Gabriela Riemekasten; Alexander Kreuter; Madelon C Vonk; Rafaella Scorza; Lorenzo Beretta; Paulo Airò; Piet L C M van Riel; Robert Kimberly; Javier Martin; Jeffrey Edberg; Timothy R D J Radstake
The functional polymorphism 844 A>G in FcαRI (CD89) does not contribute to systemic sclerosis or rheumatoid arthritis susceptibility.
The Journal of rheumatology 2011;38(3):446-9.
2011: Henrik Källberg; Bo Ding; Leonid Padyukov; Camilla Bengtsson; Johan Rönnelid; Lars Klareskog; Lars Alfredsson
Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke.
Annals of the rheumatic diseases 2011;70(3):508-11.
2011: Marleen G H van de Sande; Danielle M Gerlag; Beatrijs M Lodde; Lisa G M van Baarsen; Stefano Alivernini; Veronica Codullo; Ioana Felea; Elsa Vieira-Sousa; Ursula Fearon; Richard Reece; Carlomaurizio Montecucco; Douglas J Veale; Costantino Pitzalis; Paul Emery; Lars Klareskog; Iain B McInnes; Paul P Tak
Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisation to be used in clinical trials.
Annals of the rheumatic diseases 2011;70(3):423-7.
2011: M Neovius; Jf Simard; Annika Sundström; L Jacobsson; Pierre Geborek; T Saxne; Nils Feltelius; Lars Klareskog; Johan Askling
Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register.
Annals of the rheumatic diseases 2011;70(3):516-9.
2011: Leonid Padyukov; Mark Seielstad; Rick T H Ong; Bo Ding; Johan Rönnelid; Maria Seddighzadeh; Lars Alfredsson; Lars Klareskog
A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis.
Annals of the rheumatic diseases 2011;70(2):259-65.
2011: Keith Humphreys; Lars Klareskog; Monica Leu; Paul Lichtenstein; Jianjun Liu; Ole A Andreassen; Bo Ding; Alexander Grankvist; Henrik Grönberg; Leif Groop; Per Hall; Christina M Hultman; Morten Mattingsdal; Colm O'Dushlaine; Juni Palmgren; Nancy L Pedersen; Shaun M Purcell; Karola Rehnström; Samuli Ripatti; Pamela Sklar; Patrick F Sullivan; Jianfeng Xu; Patrik K E Magnusson
The genetic structure of the Swedish population.
PloS one 2011;6(8):e22547.
2011: Too Chun-Lai; Jasbir Singh Dhaliwal; Lars Klareskog; Per Tobias Larsson; Emeli Lundström; Nor Asiah Muhamad; Shahnaz Murad; Leonid Padyukov; Abqariyah Yahya; Lars Alfredsson
Shared epitope alleles remain a risk factor for anti-citrullinated proteins antibody (ACPA)--positive rheumatoid arthritis in three Asian ethnic groups.
PloS one 2011;6(6):e21069.
2011: Saedis Saevarsdottir; Kristjan Steinsson; Helgi Valdimarsson; Lars Alfredsson; Bo Ding; Gerdur Grondal; Lars Klareskog; Leonid Padyukov
Mannan Binding Lectin (MBL) genotypes coding for high MBL serum levels are associated with rheumatoid factor negative rheumatoid arthritis in never smokers.
Arthritis research & therapy 2011;13(2):R65.
2011: Emeli Lundström; Toinette Hartshorne; Kelly Li; Staffan Lindblad; MC Wick; Camilla Bengtsson; Lars Alfredsson; Lars Klareskog; Leonid Padyukov
Effects of GSTM1 in rheumatoid arthritis; results from the Swedish EIRA study.
PloS one 2011;6(3):e17880.
2011: Julia F Simard; Elizabeth V Arkema; Anders Sundström; Pierre Geborek; Tore Saxne; Eva Baecklund; Lars Coster; Christina Dackhammar; Lennart Jacobsson; Nils Feltelius; Staffan Lindblad; Solbritt Rantapää-Dahlqvist; Lars Klareskog; Ronald van Vollenhoven; Martin Neovius; Johan Askling
Ten years with biologics: to whom do data on effectiveness and safety apply?
Rheumatology (Oxford, England) 2011;50(1):204-13.
2011: M Neovius; Annika Sundström; Jf Simard; B Wettermark; T Cars; Nils Feltelius; Johan Askling; Lars Klareskog
Small-area variations in sales of TNF inhibitors in Sweden between 2000 and 2009.
Scandinavian journal of rheumatology 2011;40(1):8-15.
2011: Saedis Saevarsdottir; Sara Wedrén; Maria Seddighzadeh; Camilla Bengtsson; Annmarie Wesley; Staffan Lindblad; Johan Askling; Lars Alfredsson; Lars Klareskog
Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Register cohorts.
Arthritis and rheumatism 2011;63(1):26-36.
2010: Lars Klareskog; Peter K Gregersen; Tom W J Huizinga
Prevention of autoimmune rheumatic disease: state of the art and future perspectives.
Annals of the rheumatic diseases 2010;69(12):2062-6.
2010: M E Holmqvist; Sara Wedrén; L T H Jacobsson; Lars Klareskog; F Nyberg; Solbritt Rantapää-Dahlqvist; L Alfredsson; Johan Askling
Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006.
Journal of internal medicine 2010;268(6):578-85.
2010: Ulrike Hüffmeier; Steffen Uebe; Arif B Ekici; John Bowes; Emiliano Giardina; Eleanor Korendowych; Kristina Juneblad; Maria Apel; Ross McManus; Pauline Ho; Ian N Bruce; Anthony Ryan; Frank Behrens; Jesús Lascorz; Beate Böhm; Heiko Traupe; Jörg Lohmann; Christian Gieger; Heinz-Erich Wichmann; Christine Herold; Michael Steffens; Lars Klareskog; Thomas F Wienker; Oliver Fitzgerald; Gerd-Marie Alenius; Neil J McHugh; Giuseppe Novelli; Harald Burkhardt; Anne Barton; André Reis
Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis.
Nature genetics 2010;42(11):996-9.
2010: Brendan T Keenan; Lori B Chibnik; Jing Cui; Bo Ding; Leonid Padyukov; Henrik Kallberg; Camilla Bengtsson; Lars Klareskog; Lars Alfredsson; Elizabeth W Karlson
Effect of interactions of glutathione S-transferase T1, M1, and P1 and HMOX1 gene promoter polymorphisms with heavy smoking on the risk of rheumatoid arthritis.
Arthritis and rheumatism 2010;62(11):3196-210.
2010: Camilla Bengtsson; Meliha C Kapetanovic; Henrik Källberg; Berit Sverdrup; B Nordmark; Lars Klareskog; Lars Alfredsson
Common vaccinations among adults do not increase the risk of developing rheumatoid arthritis: results from the Swedish EIRA study.
Annals of the rheumatic diseases 2010;69(10):1831-3.
2010: Ricardo C Ferreira; Qiang Pan-Hammarstrom; Robert R Graham; Vesela Gateva; Gumersindo Fontán; Annette T Lee; Ward Ortmann; Elena Urcelay; Miguel Fernández-Arquero; Concepción Núñez; Gudmundur Jorgensen; Björn R Ludviksson; Sinikka Koskinen; Katri Haimila; Hilary F Clark; Lars Klareskog; Peter K Gregersen; timothy wayne behrens; Lennart Hammarström
Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency.
Nature genetics 2010;42(9):777-80.
2010: Darren Plant; Edward Flynn; Hamdi Mbarek; Philippe Dieudé; François Cornelis; Lisbeth Arlestig; Solbritt Rantapää Dahlqvist; George Goulielmos; Dimitrios T Boumpas; Prodromos Sidiropoulos; Julia S Johansen; Lykke M Ørnbjerg; Merete Lund Hetland; Lars Klareskog; Andrew Filer; Christopher D Buckley; Karim Raza; Torsten Witte; Reinhold E Schmidt; Jane Worthington
Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers.
Annals of the rheumatic diseases 2010;69(8):1548-53.
2010: Camilla Bengtsson; A Berglund; M-L Serra; L Nise; B Nordmark; Lars Klareskog; Lars Alfredsson
Non-participation in EIRA: a population-based case-control study of rheumatoid arthritis.
Scandinavian journal of rheumatology 2010;39(4):344-6.
2010: Amalia P Raptopoulou; George Bertsias; Dimitrios Makrygiannakis; Panayotis Verginis; Iraklis Kritikos; Maria Tzardi; Lars Klareskog; Anca I Catrina; Prodromos Sidiropoulos; Dimitrios T Boumpas
The programmed death 1/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis.
Arthritis and rheumatism 2010;62(7):1870-80.
2010: Maria Seddighzadeh; Marina Korotkova; Henrik Källberg; Bo Ding; Nina Daha; Fina A S Kurreeman; Rene E M Toes; Tom W Huizinga; Anca Irinel Catrina; Lars Alfredsson; Lars Klareskog; Leonid Padyukov
Evidence for interaction between 5-hydroxytryptamine (serotonin) receptor 2A and MHC type II molecules in the development of rheumatoid arthritis.
European journal of human genetics : EJHG 2010;18(7):821-6.
2010: Edward Keystone; Mark C Genovese; Lars Klareskog; Elizabeth C Hsia; Stephen Hall; Pedro C Miranda; Jacek Pazdur; Sang-Cheol Bae; William Palmer; Stephen Xu; Mahboob U Rahman
Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study.
Annals of the rheumatic diseases 2010;69(6):1129-35.
2010: Elizabeth W Karlson; Lori B Chibnik; Peter Kraft; Jing Cui; Brendan T Keenan; Bo Ding; Souyma Raychaudhuri; Lars Klareskog; Lars Alfredsson; Robert M Plenge
Cumulative association of 22 genetic variants with seropositive rheumatoid arthritis risk.
Annals of the rheumatic diseases 2010;69(6):1077-85.
2010: Patrik Stolt; Abqariyah Yahya; Camilla Bengtsson; Henrik Källberg; Johan Rönnelid; Ingrid Lundberg; Lars Klareskog; Lars Alfredsson
Silica exposure among male current smokers is associated with a high risk of developing ACPA-positive rheumatoid arthritis.
Annals of the rheumatic diseases 2010;69(6):1072-6.
2010: Monika Hermansson; Konstantin Artemenko; Elena Ossipova; Hanna Eriksson; Johan Lengqvist; Dimitrios Makrygiannakis; Anca I Catrina; Anthony P Nicholas; Lars Klareskog; Mikhail Savitski; Roman A Zubarev; Per-Johan Jakobsson
MS analysis of rheumatoid arthritic synovial tissue identifies specific citrullination sites on fibrinogen.
Proteomics. Clinical applications 2010;4(5):511-8.
2010: Diane van der Woude; Benedicte Lie; Emeli Lundström; Alejandro Balsa; Anouk L Feitsma; Jeanine J Houwing-Duistermaat; Willem Verduijn; Gry B N Nordang; Lars Alfredsson; Lars Klareskog; Dora Pascual-Salcedo; Miguel A Gonzalez-Gay; Miguel A Lopez-Nevot; Fernando Valero; Bart O Roep; Tom W J Huizinga; Tore K Kvien; Javier Martín; Leonid Padyukov; René R P De Vries; René E M Toes
Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in four European populations.
Arthritis and rheumatism 2010;62(5):1236-45.
2010: Marieke Coenen; Christian Enevold; Pilar Barrera; Mascha M V A P Schijvenaars; Erik J M Toonen; Hans Scheffer; Leonid Padyukov; Alf Kastbom; Lars Klareskog; Anne Barton; W Kievit; Maarten J Rood; Tim L Jansen; Dorine W Swinkels; Piet L C M van Riel; Barbara Franke; Klaus Bendtzen; Timothy R D J Radstake
Genetic variants in toll-like receptors are not associated with rheumatoid arthritis susceptibility or anti-tumour necrosis factor treatment outcome.
PloS one 2010;5(12):e14326.
2010: Sudha Visvanathan; Mahboob U Rahman; Edward Keystone; Mark Genovese; Lars Klareskog; Elizabeth Hsia; Michael Mack; Jacqui Buchanan; Michael Elashoff; Carrie Wagner
Association of serum markers with improvement in clinical response measures after treatment with golimumab in patients with active rheumatoid arthritis despite receiving methotrexate: results from the GO-FORWARD study.
Arthritis research & therapy 2010;12(6):R211.
2010: Johan Lindberg; Carla A Wijbrandts; Lisa G van Baarsen; Gustavo Nader; Lars Klareskog; Anca Catrina; Rogier Thurlings; Margriet Vervoordeldonk; Joakim Lundeberg; Paul P Tak
The gene expression profile in the synovium as a predictor of the clinical response to infliximab treatment in rheumatoid arthritis.
PloS one 2010;5(6):e11310.
2010: Mauro D'Amato; Marco Zucchelli; Maria Seddighzadeh; Francesca Anedda; Staffan Lindblad; Juha Kere; Lars Alfredsson; Lars Klareskog; Leonid Padyukov
Analysis of neuropeptide S receptor gene (NPSR1) polymorphism in rheumatoid arthritis.
PloS one 2010;5(2):e9315.
2010: Omri Snir; Mona Widhe; Monika Hermansson; Caroline von Spee; Johan Lindberg; Sanne Hensen; Karin Lundberg; Ake Engström; Patrick J W Venables; René E M Toes; Rikard Holmdahl; Lars Klareskog; Vivianne Malmström
Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.
Arthritis and rheumatism 2010;62(1):44-52.
2009: Hiba Mahdi; Benjamin A Fisher; Henrik Källberg; Darren Plant; Vivianne Malmström; Johan Rönnelid; Peter Charles; Bo Ding; Lars Alfredsson; Leonid Padyukov; Deborah Symmons; Patrick J Venables; Lars Klareskog; Karin Lundberg
Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis.
Nature genetics 2009;41(12):1319-24.
2009: John D Rioux; Philippe Goyette; Timothy J Vyse; Lennart Hammarström; Michelle M A Fernando; Todd Green; Philip L De Jager; Sylvain Foisy; Joanne Wang; Paul I W de Bakker; Stephen Leslie; Gilean McVean; Leonid Padyukov; Lars Alfredsson; Vito Annese; David A Hafler; Qiang Pan-Hammarstrom; Ritva Matell; Stephen J Sawcer; Alastair D Compston; Bruce A C Cree; Daniel B Mirel; Mark J Daly; timothy wayne behrens; Lars Klareskog; Peter K Gregersen; Jorge R Oksenberg; Stephen L Hauser
Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(44):18680-5.
2009: Johan Askling; Ronald van Vollenhoven; Fredrik Granath; Pauline Raaschou; C Michael Fored; Eva Baecklund; Christina Dackhammar; Nils Feltelius; Lars Cöster; Pierre Geborek; L T H Jacobsson; Staffan Lindblad; Solbritt Rantapää-Dahlqvist; Tore Saxne; Lars Klareskog
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?
Arthritis and rheumatism 2009;60(11):3180-9.
2009: Magdalena S Rosell; Ann-Marie Wesley; Karin Rydin; Lars Klareskog; Lars Alfredsson
Dietary fish and fish oil and the risk of rheumatoid arthritis.
Epidemiology (Cambridge, Mass.) 2009;20(6):896-901.
2009: Chao Tian; Roman Kosoy; Rami Nassir; Annette Lee; Pablo Villoslada; Lars Klareskog; Lennart Hammarström; Henri-Jean Garchon; Ann E Pulver; Michael Ransom; Peter K Gregersen; Michael F Seldin
European population genetic substructure: further definition of ancestry informative markers for distinguishing among diverse European ethnic groups.
Molecular medicine (Cambridge, Mass.) 2009;15(11-12):371-83.
2009: Marie E Holmqvist; Sara Wedrén; Lennart T H Jacobsson; Lars Klareskog; Fredrik Nyberg; Solbritt Rantapää-Dahlqvist; Lars Alfredsson; Johan Askling
No increased occurrence of ischemic heart disease prior to the onset of rheumatoid arthritis: results from two Swedish population-based rheumatoid arthritis cohorts.
Arthritis and rheumatism 2009;60(10):2861-9.
2009: Lena Svelander; Helena Erlandsson Harris; Leif Astner; Urszula Grabowska; Lars Klareskog; Erik Lindstrom; Ellen Hewitt
Inhibition of cathepsin K reduces bone erosion, cartilage degradation and inflammation evoked by collagen-induced arthritis in mice.
European journal of pharmacology 2009;613(1-3):155-62.
2009: Emeli Lundström; Henrik Källberg; Lars Alfredsson; Lars Klareskog; Leonid Padyukov
Gene-environment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis: all alleles are important.
Arthritis and rheumatism 2009;60(6):1597-603.
2009: Yvonne C Lee; Soumya Raychaudhuri; Jing Cui; Immaculata DeVivo; Bo Ding; Lars Alfredsson; Leonid Padyukov; Karen H Costenbader; Mark Seielstad; Robert R Graham; Lars Klareskog; Peter K Gregersen; Robert M Plenge; Elizabeth W Karlson
The PRL -1149 G/T polymorphism and rheumatoid arthritis susceptibility.
Arthritis and rheumatism 2009;60(5):1250-4.
2009: O Snir; M Widhe; C von Spee; J Lindberg; Leonid Padyukov; K Lundberg; A Engström; P J Venables; J Lundeberg; R Holmdahl; Lars Klareskog; V Malmström
Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
Annals of the rheumatic diseases 2009;68(5):736-43.
2009: Johan Askling; E Baecklund; Fredrik Granath; P Geborek; M Fored; C Backlin; L Bertilsson; L Cöster; L T Jacobsson; S Lindblad; J Lysholm; Solbritt Rantapää-Dahlqvist; T Saxne; Ronald van Vollenhoven; Lars Klareskog; Nils Feltelius
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register.
Annals of the rheumatic diseases 2009;68(5):648-53.
2009: Emeli Lundström; Henrik Källberg; Marina Smolnikova; Bo Ding; Johan Rönnelid; Lars Alfredsson; Lars Klareskog; Leonid Padyukov
Opposing effects of HLA-DRB1*13 alleles on the risk of developing anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
Arthritis and rheumatism 2009;60(4):924-30.
2009: Lars Klareskog; Sara Wedrén; Lars Alfredsson
On the origins of complex immune-mediated disease: the example of rheumatoid arthritis.
Journal of molecular medicine (Berlin, Germany) 2009;87(4):357-62.
2009: Katherine P Liao; Marie Gunnarsson; Henrik Källberg; Bo Ding; Robert M Plenge; Leonid Padyukov; Elizabeth W Karlson; Lars Klareskog; Johan Askling; Lars Alfredsson
Specific association of type 1 diabetes mellitus with anti-cyclic citrullinated peptide-positive rheumatoid arthritis.
Arthritis and rheumatism 2009;60(3):653-60.
2009: Lars Klareskog; Anca Irinel Catrina; Stephen Paget
Rheumatoid arthritis.
Lancet 2009;373(9664):659-72.
2009: Henrik Källberg; S Jacobsen; Camilla Bengtsson; M Pedersen; Leonid Padyukov; P Garred; Morten Frisch; E W Karlson; Lars Klareskog; Lars Alfredsson
Alcohol consumption is associated with decreased risk of rheumatoid arthritis: results from two Scandinavian case-control studies.
Annals of the rheumatic diseases 2009;68(2):222-7.
2009: Erik af Klint; Anca Irinel Catrina; Peter Matt; Petra Neregråd; Jon Lampa; Ann-Kristin Ulfgren; Lars Klareskog; Staffan Lindblad
Evaluation of arthroscopy and macroscopic scoring.
Arthritis research & therapy 2009;11(3):R81.
2009: Wolfgang Hueber; Beren H Tomooka; Franak Batliwalla; Wentian Li; Paul A Monach; Robert J Tibshirani; Ronald van Vollenhoven; Jon Lampa; Kazuyoshi Saito; Yoshiya Tanaka; Mark C Genovese; Lars Klareskog; Peter K Gregersen; William H Robinson
Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis.
Arthritis research & therapy 2009;11(3):R76.
2009: Camilla Bengtsson; Tores Theorell; Lars Klareskog; Lars Alfredsson
Psychosocial stress at work and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study.
Psychotherapy and psychosomatics 2009;78(3):193-4.
2009: Bo Ding; Leonid Padyukov; Emeli Lundström; Mark Seielstad; Robert M Plenge; Jorge R Oksenberg; Peter K Gregersen; Lars Alfredsson; Lars Klareskog
Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region.
Arthritis and rheumatism 2009;60(1):30-8.
2008: Therese Vallerskog; Hans Gaines; Adina Feldman; Eric Culbert; Lars Klareskog; Vivianne Malmström; Christina Trollmo
Serial re-challenge with influenza vaccine as a tool to study individual immune responses.
Journal of immunological methods 2008;339(2):165-74.
2008: Anca Irinel Catrina; Lars Klareskog
Effects of disease-modifying antirheumatic drug treatment on the expression of RANKL and osteoprotegerin in synovial tissue: comment on the article by Haynes et al.
Arthritis and rheumatism 2008;59(11):1685; author reply 1685-6.
2008: Annette H M Van Der Helm-Van Mil; Leonid Padyukov; René E M Toes; Lars Klareskog; Tom W J Huizinga
Genome-wide single-nucleotide polymorphism studies in rheumatology: hype or hope?
Arthritis and rheumatism 2008;58(9):2591-7.
2008: Ming Gu; Maria Kakoulidou; Ricardo Giscombe; Ritva Pirskanen; Ann Kari Lefvert; Lars Klareskog; Xiongbiao Wang
Identification of CTLA-4 isoforms produced by alternative splicing and their association with myasthenia gravis.
Clinical immunology (Orlando, Fla.) 2008;128(3):374-81.
2008: Désirée van der Heijde; Robert Landewé; Ronald van Vollenhoven; Saeed Fatenejad; Lars Klareskog
Level of radiographic damage and radiographic progression are determinants of physical function: a longitudinal analysis of the TEMPO trial.
Annals of the rheumatic diseases 2008;67(9):1267-70.
2008: Lars Klareskog; Mona Widhe; Monika Hermansson; Johan Rönnelid
Antibodies to citrullinated proteins in arthritis: pathology and promise.
Current opinion in rheumatology 2008;20(3):300-5.
2008: Eva Baecklund; Yasodha Natkunam; Carin Backlin; Anastasia Iliadou; Johan Askling; Anders Ekbom; Nils Feltelius; Lars Klareskog; Gunilla Enblad; Izidore S Lossos; Ronald Levy; Christer Sundström; Richard Rosenquist
Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis.
British journal of haematology 2008;141(1):69-72.
2008: Ewa Westman; D D Thi Ngoc; Lars Klareskog; Helena Erlandsson Harris
Suppressive effects of a quinoxaline-analogue (Rob 803) on pathogenic immune mechanisms in collagen-induced arthritis.
Clinical and experimental immunology 2008;152(1):192-9.
2008: T Jónsdóttir; Iva Gunnarsson; A Risselada; E W Henriksson; Lars Klareskog; Ronald van Vollenhoven
Treatment of refractory SLE with rituximab plus cyclophosphamide: clinical effects, serological changes, and predictors of response.
Annals of the rheumatic diseases 2008;67(3):330-4.
2008: Daniel Tracey; Lars Klareskog; Eric H Sasso; Jochen G Salfeld; Paul P Tak
Tumor necrosis factor antagonist mechanisms of action: a comprehensive review.
Pharmacology & therapeutics 2008;117(2):244-79.
2008: Chao Tian; Robert M Plenge; Michael Ransom; Annette Lee; Pablo Villoslada; Carlo Selmi; Lars Klareskog; Ann E Pulver; Lihong Qi; Peter K Gregersen; Michael F Seldin
Analysis and application of European genetic substructure using 300 K SNP information.
PLoS genetics 2008;4(1):e4.
2008: Lars Klareskog; Johan Rönnelid; Karin Lundberg; Leonid Padyukov; Lars Alfredsson
Immunity to citrullinated proteins in rheumatoid arthritis.
Annual review of immunology 2008;26():651-75.
2008: Linda Mathsson; Mohammed Mullazehi; MC Wick; Olof Sjöberg; Ronald van Vollenhoven; Lars Klareskog; Johan Rönnelid
Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides.
Arthritis and rheumatism 2008;58(1):36-45.
2008: Irun R Cohen; Lars Klareskog
Antiinflammatory therapy for rheumatoid arthritis?
Arthritis and rheumatism 2008;58(1):2-4.
2007: Désirée van der Heijde; Lars Klareskog; Robert Landewé; G A W Bruyn; A Cantagrel; P Durez; G Herrero-Beaumont; Y Molad; Catalin Codreanu; G Valentini; R Zahora; Ronald Pedersen; D MacPeek; Joseph Wajdula; S Fatenejad
Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis.
Arthritis and rheumatism 2007;56(12):3928-39.
2007: Ronald van Vollenhoven; Lars Klareskog
Infliximab dosage and infusion frequency in clinical practice: experiences in the Stockholm biologics registry STURE.
Scandinavian journal of rheumatology 2007;36(6):418-23.
2007: Angela L Zhang; Paula Colmenero; Ulrich Purath; Cristina Teixeira de Matos; Wolfgang Hueber; Lars Klareskog; Ingo H Tarner; Edgar G Engleman; Kalle Söderström
Natural killer cells trigger differentiation of monocytes into dendritic cells.
Blood 2007;110(7):2484-93.
2007: Johan Askling; C Michael Fored; Lena Brandt; Eva Baecklund; Lennart Bertilsson; Nils Feltelius; Lars Cöster; Pierre Geborek; L T H Jacobsson; Staffan Lindblad; Jörgen Lysholm; Solbritt Rantapää-Dahlqvist; Tore Saxne; Ronald van Vollenhoven; Lars Klareskog
Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists.
Annals of the rheumatic diseases 2007;66(10):1339-44.
2007: Robert M Plenge; Mark Seielstad; Leonid Padyukov; Annette T Lee; Elaine F Remmers; Bo Ding; Anthony Liew; Houman Khalili; Alamelu Chandrasekaran; Leela R L Davies; Wentian Li; Adrian K S Tan; Carine Bonnard; Rick T H Ong; Anbupalam Thalamuthu; Sven Pettersson; Chunyu Liu; Chao Tian; Wei V Chen; John P Carulli; Evan M Beckman; David Altshuler; Lars Alfredsson; Lindsey A Criswell; Christopher I Amos; Michael F Seldin; Daniel Kastner; Lars Klareskog; Peter K Gregersen
TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study.
The New England journal of medicine 2007;357(12):1199-209.
2007: Elaine F Remmers; Robert M Plenge; Annette T Lee; Robert R Graham; Geoffrey Hom; timothy wayne behrens; Paul I W de Bakker; Julie M Le; Hye-Soon Lee; Franak M Batliwalla; Wentian Li; seth masters; Matthew G Booty; John P Carulli; Leonid Padyukov; Lars Alfredsson; Lars Klareskog; Wei V Chen; Christopher I Amos; Lindsey A Criswell; Michael F Seldin; Daniel Kastner; Peter K Gregersen
STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus.
The New England journal of medicine 2007;357(10):977-86.
2007: Birgitta Tengstrand; E Larsson; Lars Klareskog; Ingiäld Hafström
Randomized withdrawal of long-term prednisolone treatment in rheumatoid arthritis: effects on inflammation and bone mineral density.
Scandinavian journal of rheumatology 2007;36(5):351-8.
2007: Fina A S Kurreeman; Leonid Padyukov; Rute B Marques; Steven J Schrodi; Maria Seddighzadeh; Gerrie Stoeken-Rijsbergen; Annette H M Van Der Helm-Van Mil; Cornelia F Allaart; Willem Verduyn; Jeanine J Houwing-Duistermaat; Lars Alfredsson; Ann B Begovich; Lars Klareskog; Tom W J Huizinga; René E M Toes
A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis.
PLoS medicine 2007;4(9):e278.
2007: Johnny C Lorentzen; Line Flornes; Carina Eklöw; Liselotte Bäckdahl; Ulrica Ribbhammar; Jian Ping Guo; Marina Smolnikova; Erik Dissen; Maria Seddighzadeh; Anthony J Brookes; Lars Alfredsson; Lars Klareskog; Leonid Padyukov; Sigbjörn Fossum
Association of arthritis with a gene complex encoding C-type lectin-like receptors.
Arthritis and rheumatism 2007;56(8):2620-32.
2007: Snaevar Sigurdsson; Leonid Padyukov; Fina A S Kurreeman; Ulrika Liljedahl; Ann-Christin Wiman; Lars Alfredsson; René Toes; Johan Rönnelid; Lars Klareskog; Tom W J Huizinga; Gunnar V Alm; Ann-Christine Syvänen; Lars Rönnblom
Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis.
Arthritis and rheumatism 2007;56(7):2202-10.
2007: Henrik Kallberg; Leonid Padyukov; Robert M Plenge; Johan Ronnelid; Peter K Gregersen; Annette H M Van Der Helm-Van Mil; René E M Toes; Tom W Huizinga; Lars Klareskog; Lars Alfredsson
Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis.
American journal of human genetics 2007;80(5):867-75.
2007: Christina Trollmo; Sveinn Gudmundsson; Nils Feltelius; Siv Rogberg; Göran Smedegård; Lars Klareskog
Sulphasalazine inhibits human antigen-specific immune responses in vivo.
Annals of the rheumatic diseases 2007;66(4):481-5.
2007: Désirée van der Heijde; Lars Klareskog
Reply to letter by Yazici and Yazici commenting on the two-year report on the trial of etanercept and methotrexate with radiographic and patient outcomes.
Arthritis and rheumatism 2007;56(3):1031-2.
2007: Cecilia Carlens; Lena Brandt; Lars Klareskog; Jon Lampa; Johan Askling
The inflammatory reflex and risk for rheumatoid arthritis: a case-control study of human vagotomy.
Annals of the rheumatic diseases 2007;66(3):414-6.
2007: Lina M Olsson; Anna-Karin Lindqvist; Henrik Källberg; Leonid Padyukov; Harald Burkhardt; Lars Alfredsson; Lars Klareskog; Rikard Holmdahl
A case-control study of rheumatoid arthritis identifies an associated single nucleotide polymorphism in the NCF4 gene, supporting a role for the NADPH-oxidase complex in autoimmunity.
Arthritis research & therapy 2007;9(5):R98.
2007: Lars Klareskog; Leonid Padyukov; Lars Alfredsson
Smoking as a trigger for inflammatory rheumatic diseases.
Current opinion in rheumatology 2007;19(1):49-54.
2007: Therese Vallerskog; Iva Gunnarsson; Mona Widhe; Anke Risselada; Lars Klareskog; Ronald van Vollenhoven; Vivianne Malmström; Christina Trollmo
Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE.
Clinical immunology (Orlando, Fla.) 2007;122(1):62-74.
2006: Paul Lichtenstein; Patrick F Sullivan; Sven Cnattingius; Margaret Gatz; Sofie Johansson; Eva Carlström; Camilla Björk; Magnus Svartengren; Alicja Wolk; Lars Klareskog; Ulf de Faire; Martin Schalling; Juni Palmgren; Nancy L Pedersen
The Swedish Twin Registry in the third millennium: an update.
Twin research and human genetics : the official journal of the International Society for Twin Studies 2006;9(6):875-82.
2006: Eva Baecklund; Carin Backlin; Anastasia Iliadou; Fredrik Granath; Anders Ekbom; Rose-Marie Amini; Nils Feltelius; Gunilla Enblad; Christer Sundström; Lars Klareskog; Johan Askling; Richard Rosenquist
Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis.
Arthritis and rheumatism 2006;54(12):3774-81.
2006: Lars Klareskog; Leonid Padyukov; Johan Rönnelid; Lars Alfredsson
Genes, environment and immunity in the development of rheumatoid arthritis.
Current opinion in immunology 2006;18(6):650-5.
2006: Lars Klareskog; M Gaubitz; Vicente Rodriguez-Valverde; Michel Malaise; Maxime Dougados; Joseph Wajdula
A long-term, open-label trial of the safety and efficacy of etanercept (Enbrel) in patients with rheumatoid arthritis not treated with other disease-modifying antirheumatic drugs.
Annals of the rheumatic diseases 2006;65(12):1578-84.
2006: Lars Klareskog
Clinical databases and biobanks for etiologic and therapeutic studies in rheumatoid arthritis.
Nature clinical practice. Rheumatology 2006;2(10):517.
2006: Robert Landewé; Désirée van der Heijde; Lars Klareskog; Ronald van Vollenhoven; Saeed Fatenejad
Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes.
Arthritis and rheumatism 2006;54(10):3119-25.
2006: Michael F Seldin; Russell Shigeta; Pablo Villoslada; Carlo Selmi; Jaakko Tuomilehto; Gabriel Silva; John W Belmont; Lars Klareskog; Peter K Gregersen
European population substructure: clustering of northern and southern populations.
PLoS genetics 2006;2(9):e143.
2006: Dimitrios Makrygiannakis; Erik af Klint; Ingrid E Lundberg; R Löfberg; Ann-Kristin Ulfgren; Lars Klareskog; Anca Irinel Catrina
Citrullination is an inflammation-dependent process.
Annals of the rheumatic diseases 2006;65(9):1219-22.
2006: Johan Askling; Lars Klareskog; Paul Blomqvist; M Fored; Nils Feltelius
Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study.
Annals of the rheumatic diseases 2006;65(9):1184-7.
2006: Lars Klareskog; Leonid Padyukov; Johnny C Lorentzen; Lars Alfredsson
Mechanisms of disease: Genetic susceptibility and environmental triggers in the development of rheumatoid arthritis.
Nature clinical practice. Rheumatology 2006;2(8):425-33.
2006: Duojia Cao; O Börjesson; P Larsson; A Rudin; Iva Gunnarsson; Lars Klareskog; Vivianne Malmström; Christina Trollmo
FOXP3 identifies regulatory CD25bright CD4+ T cells in rheumatic joints.
Scandinavian journal of immunology 2006;63(6):444-52.
2006: Johan Askling; C Michael Fored; Pierre Geborek; L T H Jacobsson; Ronald van Vollenhoven; Nils Feltelius; Staffan Lindblad; Lars Klareskog
Swedish registers to examine drug safety and clinical issues in RA.
Annals of the rheumatic diseases 2006;65(6):707-12.
2006: L Björnådal; L Brandt; Lars Klareskog; Johan Askling
Impact of parental history on patients' cardiovascular mortality in rheumatoid arthritis.
Annals of the rheumatic diseases 2006;65(6):741-5.
2006: Dimitrios Makrygiannakis; Erik af Klint; Sergiu-Bogdan Catrina; Ileana Ruxandra Botusan; Elin Klareskog; Lars Klareskog; Ann-Kristin Ulfgren; Anca Irinel Catrina
Intraarticular corticosteroids decrease synovial RANKL expression in inflammatory arthritis.
Arthritis and rheumatism 2006;54(5):1463-72.
2006: Désirée van der Heijde; Lars Klareskog; Vicente Rodriguez-Valverde; Catalin Codreanu; Horatiu Bolosiu; Jose Melo-Gomes; Jesus Tornero-Molina; Joseph Wajdula; Ronald Pedersen; Saeed Fatenejad
Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial.
Arthritis and rheumatism 2006;54(4):1063-74.
2006: Eva Baecklund; Anastasia Iliadou; Johan Askling; Anders Ekbom; Carin Backlin; Fredrik Granath; Anca Irinel Catrina; Richard Rosenquist; Nils Feltelius; Christer Sundström; Lars Klareskog
Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis.
Arthritis and rheumatism 2006;54(3):692-701.
2006: Désirée van der Heijde; Lars Klareskog; A Singh; J Tornero; J Melo-Gomes; Catalin Codreanu; Ronald Pedersen; B Freundlich; Saeed Fatenejad
Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial.
Annals of the rheumatic diseases 2006;65(3):328-34.
2006: Johan Lindberg; Erik af Klint; Anca Irinel Catrina; Peter Nilsson; Lars Klareskog; Ann-Kristin Ulfgren; Joakim Lundeberg
Effect of infliximab on mRNA expression profiles in synovial tissue of rheumatoid arthritis patients.
Arthritis research & therapy 2006;8(6):R179.
2006: Johan Lindberg; Erik af Klint; Ann-Kristin Ulfgren; André Stark; Tove Andersson; Peter Nilsson; Lars Klareskog; Joakim Lundeberg
Variability in synovial inflammation in rheumatoid arthritis investigated by microarray technology.
Arthritis research & therapy 2006;8(2):R47.
2006: Sofia Ernestam; Erik af Klint; Anca Irinel Catrina; Erik Sundberg; Marianne Engström; Lars Klareskog; Ann-Kristin Ulfgren
Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor.
Arthritis research & therapy 2006;8(1):R18.
2006: B Nordmark; P Blomqvist; B Andersson; M Hägerström; K Nordh-Grate; R Rönnqvist; H Svensson; Lars Klareskog
A two-year follow-up of work capacity in early rheumatoid arthritis: a study of multidisciplinary team care with emphasis on vocational support.
Scandinavian journal of rheumatology 2006;35(1):7-14.
2006: Anca Irinel Catrina; Erik af Klint; Sofia Ernestam; Sergiu-Bogdan Catrina; Dimitrios Makrygiannakis; Ileana Ruxandra Botusan; Lars Klareskog; Ann-Kristin Ulfgren
Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis.
Arthritis and rheumatism 2006;54(1):76-81.
2006: Lars Klareskog; Patrik Stolt; Karin Lundberg; Henrik Källberg; Camilla Bengtsson; Johan Grunewald; Johan Rönnelid; Helena Erlandsson Harris; Ann-Kristin Ulfgren; Solbritt Rantapää-Dahlqvist; Anders Eklund; Leonid Padyukov; Lars Alfredsson
A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination.
Arthritis and rheumatism 2006;54(1):38-46.
2005: Robert M Plenge; Leonid Padyukov; Elaine F Remmers; Shaun Purcell; Annette T Lee; Elizabeth W Karlson; Frederick Wolfe; Daniel Kastner; Lars Alfredsson; David Altshuler; Peter K Gregersen; Lars Klareskog; John D Rioux
Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4.
American journal of human genetics 2005;77(6):1044-60.
2005: Erik af Klint; Cecilia Grundtman; Marianne Engström; Anca Irinel Catrina; Dimitrios Makrygiannakis; Lars Klareskog; Ulf Andersson; Ann-Kristin Ulfgren
Intraarticular glucocorticoid treatment reduces inflammation in synovial cell infiltrations more efficiently than in synovial blood vessels.
Arthritis and rheumatism 2005;52(12):3880-9.
2005: Johan Rönnelid; MC Wick; Jon Lampa; Staffan Lindblad; B Nordmark; Lars Klareskog; Ronald van Vollenhoven
Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression.
Annals of the rheumatic diseases 2005;64(12):1744-9.
2005: Johan Askling; Lars Klareskog; Henrik Hjalgrim; Eva Baecklund; M Björkholm; Anders Ekbom
Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis.
Annals of the rheumatic diseases 2005;64(12):1765-8.
2005: Marina Korotkova; Marie Westman; Karina R Gheorghe; Erik af Klint; Christina Trollmo; Ann-Kristin Ulfgren; Lars Klareskog; Per-Johan Jakobsson
Effects of antirheumatic treatments on the prostaglandin E2 biosynthetic pathway.
Arthritis and rheumatism 2005;52(11):3439-47.
2005: Désirée van der Heijde; Lars Klareskog; M Boers; Robert Landewé; Catalin Codreanu; H D Bolosiu; Ronald Pedersen; Saeed Fatenejad
Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results.
Annals of the rheumatic diseases 2005;64(11):1582-7.
2005: Camilla Bengtsson; B Nordmark; Lars Klareskog; Ingrid Lundberg; Lars Alfredsson
Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study.
Annals of the rheumatic diseases 2005;64(11):1588-94.
2005: Johan Askling; C Michael Fored; Eva Baecklund; Lena Brandt; Carin Backlin; Anders Ekbom; C Sundström; Lennart Bertilsson; Lars Cöster; Pierre Geborek; L T H Jacobsson; Staffan Lindblad; Jörgen Lysholm; Solbritt Rantapää-Dahlqvist; Tore Saxne; Lars Klareskog; Nils Feltelius
Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists.
Annals of the rheumatic diseases 2005;64(10):1414-20.
2005: Johan Askling; C Michael Fored; Lena Brandt; Eva Baecklund; Lennart Bertilsson; Nils Feltelius; Lars Cöster; Pierre Geborek; L T H Jacobsson; Staffan Lindblad; Jörgen Lysholm; Solbritt Rantapää-Dahlqvist; Tore Saxne; Lars Klareskog
Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists.
Annals of the rheumatic diseases 2005;64(10):1421-6.
2005: MC Wick; Sofia Ernestam; Staffan Lindblad; Johan Bratt; Lars Klareskog; Ronald van Vollenhoven
Adalimumab (Humira) restores clinical response in patients with secondary loss of efficacy from infliximab (Remicade) or etanercept (Enbrel): results from the STURE registry at Karolinska University Hospital.
Scandinavian journal of rheumatology 2005;34(5):353-8.
2005: Johan Askling; C Michael Fored; Lena Brandt; Eva Baecklund; Lennart Bertilsson; Lars Cöster; Pierre Geborek; L T H Jacobsson; Staffan Lindblad; Jörgen Lysholm; Solbritt Rantapää-Dahlqvist; Tore Saxne; Victoria Romanus; Lars Klareskog; Nils Feltelius
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden.
Arthritis and rheumatism 2005;52(7):1986-92.
2005: Maria Swanberg; Olle Lidman; Leonid Padyukov; Per Eriksson; Eva Akesson; Maja Jagodic; Anna Lobell; Mohsen Khademi; Ola Börjesson; Cecilia M Lindgren; Pia Lundman; Anthony J Brookes; Juha Kere; Holger Luthman; Lars Alfredsson; Jan Hillert; Lars Klareskog; Anders Hamsten; Fredrik Piehl; Tomas Olsson
MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction.
Nature genetics 2005;37(5):486-94.
2005: Ronald van Vollenhoven; Lars Klareskog
The treatment of rheumatoid arthritis: getting better all the time?
Arthritis and rheumatism 2005;52(4):991-4.
2005: Patrik Stolt; Henrik Källberg; Ingrid Lundberg; B Sjögren; Lars Klareskog; Lars Alfredsson
Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study.
Annals of the rheumatic diseases 2005;64(4):582-6.
2005: E Larsson; Helena Erlandsson Harris; Karin Palmblad; Bengt Månsson; Tore Saxne; Lars Klareskog
CNI-1493, an inhibitor of proinflammatory cytokines, retards cartilage destruction in rats with collagen induced arthritis.
Annals of the rheumatic diseases 2005;64(3):494-6.
2005: Tony Hansson; Ingrid Dahlbom; Siv Rogberg; Britt-Inger Nyberg; Jörgen Dahlström; Göran Annerén; Lars Klareskog; Anders Dannaeus
Antitissue transglutaminase and antithyroid autoantibodies in children with Down syndrome and celiac disease.
Journal of pediatric gastroenterology and nutrition 2005;40(2):170-4; discussion 125-7.
2005: Nils Feltelius; C Michael Fored; Paul Blomqvist; Lennart Bertilsson; Pierre Geborek; L T H Jacobsson; Staffan Lindblad; Jörgen Lysholm; Solbritt Rantapää-Dahlqvist; Tore Saxne; Lars Klareskog
Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept.
Annals of the rheumatic diseases 2005;64(2):246-52.
2005: Berit Sverdrup; Henrik Källberg; Camilla Bengtsson; Ingrid Lundberg; Leonid Padyukov; Lars Alfredsson; Lars Klareskog
Association between occupational exposure to mineral oil and rheumatoid arthritis: results from the Swedish EIRA case-control study.
Arthritis research & therapy 2005;7(6):R1296-303.
2005: Karin Lundberg; Suzanne Nijenhuis; Erik R Vossenaar; Karin Palmblad; Walther J van Venrooij; Lars Klareskog; Albert J W Zendman; Helena Erlandsson Harris
Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity.
Arthritis research & therapy 2005;7(3):R458-67.
2005: Vivianne Malmström; Christina Trollmo; Lars Klareskog
Modulating co-stimulation: a rational strategy in the treatment of rheumatoid arthritis?
Arthritis research & therapy 2005;7 Suppl 2():S15-20.
2005: Anca Irinel Catrina; Christina Trollmo; Erik af Klint; Marianne Engstrom; Jon Lampa; Ylva Hermansson; Lars Klareskog; Ann-Kristin Ulfgren
Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report.
Arthritis and rheumatism 2005;52(1):61-72.
2005: Désirée van der Heijde; Robert Landewé; Lars Klareskog; Vicente Rodríguez Valverde; Lucas Settas; Ronald Pedersen; Saeed Fatenejad
Presentation and analysis of data on radiographic outcome in clinical trials: experience from the TEMPO study.
Arthritis and rheumatism 2005;52(1):49-60.
2005: Johan Frostegård; Elisabet Svenungsson; Ruihua Wu; Iva Gunnarsson; Ingrid E Lundberg; Lars Klareskog; Sohvi Hörkkö; Joseph L Witztum
Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations.
Arthritis and rheumatism 2005;52(1):192-200.
2005: MC Wick; Staffan Lindblad; Ruediger J Weiss; Lars Klareskog; Ronald van Vollenhoven
Estimated prediagnosis radiological progression: an important tool for studying the effects of early disease modifying antirheumatic drug treatment in rheumatoid arthritis.
Annals of the rheumatic diseases 2005;64(1):134-7.
2004: Johan Rönnelid; Lars Klareskog; Thomas Skogh; Björn Svensson
[Antibodies against citrullinated proteins--a breakthrough in rheumatologic diagnostics].
Läkartidningen 2004;101(50):4092-6.
2004: Lars Klareskog; Lars Alfredsson; Solbritt Rantapää-Dahlqvist; Ewa Berglin; Patrik Stolt; Leonid Padyukov
What precedes development of rheumatoid arthritis?
Annals of the rheumatic diseases 2004;63 Suppl 2():ii28-ii31.
2004: Leonid Padyukov; Camilla Silva; Patrik Stolt; Lars Alfredsson; Lars Klareskog
A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis.
Arthritis and rheumatism 2004;50(10):3085-92.
2004: T Jonsdottir; J Forslid; A van Vollenhoven; Anders Harju; S Brannemark; Lars Klareskog; Ronald van Vollenhoven
Treatment with tumour necrosis factor alpha antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies.
Annals of the rheumatic diseases 2004;63(9):1075-8.
2004: MC Wick; Staffan Lindblad; Lars Klareskog; Ronald van Vollenhoven
Relationship between inflammation and joint destruction in early rheumatoid arthritis: a mathematical description.
Annals of the rheumatic diseases 2004;63(7):848-52.
2004: Lars Klareskog; Anders Hamsten
Statins in rheumatoid arthritis--two birds with one stone?
Lancet 2004;363(9426):2011-2.
2004: Marie Westman; M Korotkova; Erik af Klint; A Stark; Laurent P Audoly; Lars Klareskog; Ann-Kristin Ulfgren; Per-Johan Jakobsson
Expression of microsomal prostaglandin E synthase 1 in rheumatoid arthritis synovium.
Arthritis and rheumatism 2004;50(6):1774-80.
2004: Ludmila Prokunina-Olsson; Leonid Padyukov; Anna Bennet; Ulf de Faire; Björn Wiman; Jonathan Prince; Lars Alfredsson; Lars Klareskog; Marta E Alarcón-Riquelme
Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope.
Arthritis and rheumatism 2004;50(6):1770-3.
2004: Eva Baecklund; Johan Askling; Richard Rosenquist; Anders Ekbom; Lars Klareskog
Rheumatoid arthritis and malignant lymphomas.
Current opinion in rheumatology 2004;16(3):254-61.
2004: Lena Björnådal; Li Yin; Fredrik Granath; Lars Klareskog; Anders Ekbom
Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95.
The Journal of rheumatology 2004;31(4):713-9.
2004: Vivianne Malmstrøm; Christina Trollmo; Lars Klareskog
The additive role of innate and adaptive immunity in the development of arthritis.
The American journal of the medical sciences 2004;327(4):196-201.
2004: E Larsson; Helena Erlandsson Harris; A Larsson; Bengt Månsson; Tore Saxne; Lars Klareskog
Corticosteroid treatment of experimental arthritis retards cartilage destruction as determined by histology and serum COMP.
Rheumatology (Oxford, England) 2004;43(4):428-34.
2004: Ronald van Vollenhoven; S Brannemark; Lars Klareskog
Dose escalation of infliximab in clinical practice: improvements seen may be explained by a regression-like effect.
Annals of the rheumatic diseases 2004;63(4):426-30.
2004: Leonid Padyukov; Ann-Marie Hytönen; Marina Smolnikova; Mirjana Hahn-Zoric; Nicklas Nilsson; Lars A Hanson; Andrej Tarkowski; Lars Klareskog
Polymorphism in promoter region of IL10 gene is associated with rheumatoid arthritis in women.
The Journal of rheumatology 2004;31(3):422-5.
2004: Lars Klareskog; Désirée van der Heijde; Julien P de Jager; Andrew Gough; Joachim R Kalden; Michel Malaise; Emilio Martín-Mola; Karel Pavelka; Jacques Sany; Lucas Settas; Joseph Wajdula; Ronald Pedersen; Saeed Fatenejad; Marie Sanda
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.
Lancet 2004;363(9410):675-81.
2004: Ingrid E Lundberg; Cecilia Grundtman; Esbjörn Larsson; Lars Klareskog
Corticosteroids--from an idea to clinical use.
Best practice & research. Clinical rheumatology 2004;18(1):7-19.
2004: Lars Klareskog; Staffan Lindblad
How is clinical progress achieved?
Best practice & research. Clinical rheumatology 2004;18(1):1-5.
2004: Ronald van Vollenhoven; Iva Gunnarsson; E Welin-Henriksson; Birgitta Sundelin; A Osterborg; Stefan H Jacobson; Lars Klareskog
Biopsy-verified response of severe lupus nephritis to treatment with rituximab (anti-CD20 monoclonal antibody) plus cyclophosphamide after biopsy-documented failure to respond to cyclophosphamide alone.
Scandinavian journal of rheumatology 2004;33(6):423-7.
2004: MC Wick; Staffan Lindblad; Ruediger J Weiss; Lars Klareskog; Ronald van Vollenhoven
Clinical and radiological disease-course in a Swedish DMARD-treated early RA-inception cohort: an observational study.
Scandinavian journal of rheumatology 2004;33(6):380-4.
2004: Duojia Cao; Ronald van Vollenhoven; Lars Klareskog; Christina Trollmo; Vivianne Malmström
CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease.
Arthritis research & therapy 2004;6(4):R335-46.
2004: Ewa Berglin; Leonid Padyukov; Ulf Sundin; Göran Hallmans; Hans Stenlund; Walther J van Venrooij; Lars Klareskog; Solbritt Rantapää Dahlqvist
A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis.
Arthritis research & therapy 2004;6(4):R303-8.
2004: Lena Svelander; Helena Erlandsson Harris; Johnny C Lorentzen; Christina Trollmo; Lars Klareskog; Anders Bucht
Oligodeoxynucleotides containing CpG motifs can induce T cell-dependent arthritis in rats.
Arthritis and rheumatism 2004;50(1):297-304.
2003: Ronald van Vollenhoven; Anders Harju; S Brannemark; Lars Klareskog
Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor alpha blockers can make sense.
Annals of the rheumatic diseases 2003;62(12):1195-8.
2003: Elisabet Svenungsson; Iva Gunnarsson; Guo-Zhong Fei; Ingrid E Lundberg; Lars Klareskog; Johan Frostegård
Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
Arthritis and rheumatism 2003;48(9):2533-40.
2003: Patrik Stolt; Camilla Bengtsson; B Nordmark; Staffan Lindblad; Ingrid Lundberg; Lars Klareskog; Lars Alfredsson
Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases.
Annals of the rheumatic diseases 2003;62(9):835-41.
2003: Sofia Ernestam; Jon Lampa; Siv Rogberg; Johan Rönnelid; Lars Klareskog; Ingiäld Hafström
Evidence for immunostimulatory effects of intramuscular gold in patients with rheumatoid arthritis: correlation with skin reactions.
The Journal of rheumatology 2003;30(8):1748-55.
2003: Eva Baecklund; Christer Sundström; Anders Ekbom; Anca Irinel Catrina; Peter Biberfeld; Nils Feltelius; Lars Klareskog
Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma.
Arthritis and rheumatism 2003;48(6):1543-50.
2003: Ronald van Vollenhoven; Lars Klareskog
Clinical responses to tumor necrosis factor alpha antagonists do not show a bimodal distribution: data from the Stockholm tumor necrosis factor alpha followup registry.
Arthritis and rheumatism 2003;48(6):1500-3.
2003: Leonid Padyukov; Jon Lampa; Mikael Heimbürger; Sofia Ernestam; T Cederholm; I Lundkvist; P Andersson; Y Hermansson; Anders Harju; Lars Klareskog; Johan Bratt
Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis.
Annals of the rheumatic diseases 2003;62(6):526-9.
2003: Karin Ekström; Henrik Hjalgrim; Lena Brandt; Eva Baecklund; Lars Klareskog; Anders Ekbom; Johan Askling
Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives.
Arthritis and rheumatism 2003;48(4):963-70.
2003: Lars Klareskog; Suad Efendic; Kerstin Brismar; Anders Hamsten
[The proposal of the National Board of Health and Welfare counteracts knowledge development within health care].
Läkartidningen 2003;100(8):631-2.
2003: Ronald van Vollenhoven; Sofia Ernestam; Anders Harju; Johan Bratt; Lars Klareskog
Etanercept versus etanercept plus methotrexate: a registry-based study suggesting that the combination is clinically more efficacious.
Arthritis research & therapy 2003;5(6):R347-51.
2003: Duojia Cao; Vivianne Malmström; Clare Baecher-Allan; David A Hafler; Lars Klareskog; Christina Trollmo
Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis.
European journal of immunology 2003;33(1):215-23.
2002: Ulf Thunberg; Gerard Tobin; Anna Johnson; Ola Söderberg; Leonid Padyukov; Magnus Hultdin; Lars Klareskog; Gunilla Enblad; Christer Sundström; Göran Roos; Richard Rosenquist
Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia.
Lancet 2002;360(9349):1935-9.
2002: Tony Hansson; Ann-Kristin Ulfgren; E Lindroos; Anders Dannaeus; Ingrid Dahlbom; Lars Klareskog
Transforming growth factor-beta (TGF-beta) and tissue transglutaminase expression in the small intestine in children with coeliac disease.
Scandinavian journal of immunology 2002;56(5):530-7.
2002: Anca Irinel Catrina; Ann-Kristin Ulfgren; Staffan Lindblad; L Grondal; Lars Klareskog
Low levels of apoptosis and high FLIP expression in early rheumatoid arthritis synovium.
Annals of the rheumatic diseases 2002;61(10):934-6.
2002: E Larsson; Helena Erlandsson Harris; Johnny C Lorentzen; A Larsson; Bengt Månsson; Lars Klareskog; Tore Saxne
Serum concentrations of cartilage oligomeric matrix protein, fibrinogen and hyaluronan distinguish inflammation and cartilage destruction in experimental arthritis in rats.
Rheumatology (Oxford, England) 2002;41(9):996-1000.
2002: Tony Hansson; Ingrid Dahlbom; Siv Rogberg; Anders Dannaeus; Peter Hopfl; Heidi Gut; Wolfgang Kraaz; Lars Klareskog
Recombinant human tissue transglutaminase for diagnosis and follow-up of childhood coeliac disease.
Pediatric research 2002;51(6):700-5.
2002: Lena Björnådal; Eva Baecklund; Li Yin; Fredrik Granath; Lars Klareskog; Anders Ekbom
Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964-95.
The Journal of rheumatology 2002;29(5):906-12.
2002: Anca Irinel Catrina; Jon Lampa; Sofia Ernestam; Erik af Klint; Johan Bratt; Lars Klareskog; Ann-Kristin Ulfgren
Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis.
Rheumatology (Oxford, England) 2002;41(5):484-9.
2002: Pernilla Englund; Inger Nennesmo; Lars Klareskog; Ingrid E Lundberg
Interleukin-1alpha expression in capillaries and major histocompatibility complex class I expression in type II muscle fibers from polymyositis and dermatomyositis patients: important pathogenic features independent of inflammatory cell clusters in muscle tissue.
Arthritis and rheumatism 2002;46(4):1044-55.
2002: Gerdur Gröndal; Kristín H Traustadottir; Helga Kristjansdottir; Ingrid Lundberg; Lars Klareskog; Kristjan Erlendsson; Kristjan Steinsson
Increased T-lymphocyte apoptosis/necrosis and IL-10 producing cells in patients and their spouses in Icelandic systemic lupus erythematosus multicase families.
Lupus 2002;11(7):435-42.
2002: Lars Klareskog; Johnny C Lorentzen; Leonid Padyukov; Lars Alfredsson
Genes and environment in arthritis: can RA be prevented?
Arthritis research 2002;4 Suppl 3():S31-6.
2002: Jon Lampa; Lars Klareskog; Johan Rönnelid
Effects of gold on cytokine production in vitro; increase of monocyte dependent interleukin 10 production and decrease of interferon-gamma levels.
The Journal of rheumatology 2002;29(1):21-8.
2001: Ingiäld Hafström; B Ringertz; A Spångberg; L von Zweigbergk; S Brannemark; I Nylander; Johan Rönnelid; Leena Laasonen; Lars Klareskog
A vegan diet free of gluten improves the signs and symptoms of rheumatoid arthritis: the effects on arthritis correlate with a reduction in antibodies to food antigens.
Rheumatology (Oxford, England) 2001;40(10):1175-9.
2001: Pernilla Englund; E Lindroos; Inger Nennesmo; Lars Klareskog; Ingrid E Lundberg
Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies.
The American journal of pathology 2001;159(4):1263-73.
2001: Elisabet Svenungsson; M Andersson; Lou Brundin; R van Vollenhoven; Mohsen Khademi; A Tarkowski; D Greitz; M Dahlström; I Lundberg; Lars Klareskog; Tomas Olsson
Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus.
Annals of the rheumatic diseases 2001;60(4):372-9.
2001: Lars Klareskog; B Nordmark; Staffan Lindblad
On the organization of an early arthritis clinic.
Best practice & research. Clinical rheumatology 2001;15(1):1-15.
2001: P Larsson; Johan Bratt; Anders Harju; Ronald van Vollenhoven; Lars Klareskog
[Blockade of TNFalpha--new therapeutic principle in severe rheumatoid arthritis].
Läkartidningen 2001;98(8):828-31.
2001: Louise Berg; Jon Lampa; Siv Rogberg; Ronald van Vollenhoven; Lars Klareskog
Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFalpha receptors.
Annals of the rheumatic diseases 2001;60(2):133-9.
2001: Adla B Hassan; Iva Gunnarsson; Göran Karlsson; Lars Klareskog; Jan Forslid; Ingrid E Lundberg
Longitudinal study of interleukin-10, tumor necrosis factor-alpha, anti-U1-snRNP antibody levels and disease activity in patients with mixed connective tissue disease.
Scandinavian journal of rheumatology 2001;30(5):282-9.
2000: Veronica Magnusson; Anna-Karin B Lindqvist; Casimiro Castillejo-López; H Kristjánsdottir; Kristjan Steinsson; Gerdur Gröndal; Gunnar Sturfelt; Lennart Truedsson; Elisabet Svenungsson; Ingrid Lundberg; Iva Gunnarsson; Anne Isine Bolstad; Hans-Jacob Haga; Roland Jonsson; Lars Klareskog; Jorge Alcocer-Varela; Donato Alarcón-Segovia; Joseph D Terwilliger; Ulf Gyllensten; Marta E Alarcón-Riquelme
Fine mapping of the SLEB2 locus involved in susceptibility to systemic lupus erythematosus.
Genomics 2000;70(3):307-14.
2000: Lars Klareskog; I Hafström; T Saxne; P J Hedin
[New drugs against rheumatoid arthritis. Improved treatment options place new demands on health care organization].
Läkartidningen 2000;97(48):5628-32.
2000: Ann-Kristin Ulfgren; Ulf Andersson; Marianne Engström; Lars Klareskog; R N Maini; P C Taylor
Systemic anti-tumor necrosis factor alpha therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor alpha synthesis.
Arthritis and rheumatism 2000;43(11):2391-6.
2000: Gerdur Gröndal; Iva Gunnarsson; Johan Rönnelid; Siv Rogberg; Lars Klareskog; Ingrid Lundberg
Cytokine production, serum levels and disease activity in systemic lupus erythematosus.
Clinical and experimental rheumatology 2000;18(5):565-70.
2000: Iva Gunnarsson; B Nordmark; A Hassan Bakri; Gerdur Gröndal; P Larsson; Jan Forslid; Lars Klareskog; B Ringertz
Development of lupus-related side-effects in patients with early RA during sulphasalazine treatment-the role of IL-10 and HLA.
Rheumatology (Oxford, England) 2000;39(8):886-93.
2000: Ann-Kristin Ulfgren; L Gröndal; Staffan Lindblad; Mohsen Khademi; O Johnell; Lars Klareskog; U Andersson
Interindividual and intra-articular variation of proinflammatory cytokines in patients with rheumatoid arthritis: potential implications for treatment.
Annals of the rheumatic diseases 2000;59(6):439-47.
2000: Paul Blomqvist; Nils Feltelius; Anders Ekbom; Lars Klareskog
Rheumatoid arthritis in Sweden. Drug prescriptions, costs, and adverse drug reactions.
The Journal of rheumatology 2000;27(5):1171-7.
2000: Ingrid Lundberg; S Antohi; K Takeuki; Frank C Arnett; G Steiner; Teodor-D Brumeanu; Lars Klareskog; Constantin A Bona
Kinetics of anti-fibrillin-1 autoantibodies in MCTD and CREST syndrome.
Journal of autoimmunity 2000;14(3):267-74.
2000: Lars Klareskog
[Current medicine requires cooperation--not omnipotence].
Läkartidningen 2000;97(17):2110-1.
2000: Tony Hansson; Ingrid Dahlbom; J Hall; A Holtz; L Elfman; Anders Dannaeus; Lars Klareskog
Antibody reactivity against human and guinea pig tissue transglutaminase in children with celiac disease.
Journal of pediatric gastroenterology and nutrition 2000;30(4):379-84.
2000: Louise Berg; Johan Rönnelid; Lars Klareskog; Anders Bucht
Down-regulation of the T cell receptor CD3 zeta chain in rheumatoid arthritis (RA) and its influence on T cell responsiveness.
Clinical and experimental immunology 2000;120(1):174-82.
2000: Lars Klareskog; I Lundberg
[Future treatment of rheumatism. A compromise in the game between inflammation and infections].
Läkartidningen 2000;97(1-2):30-3.
2000: Louise Berg; Johan Rönnelid; Carani B Sanjeevi; Jon Lampa; Lars Klareskog
Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Arthritis research 2000;2(1):75-84.
1999: Lars Klareskog; H McDevitt
Rheumatoid arthritis and its animal models: the role of TNF-alpha and the possible absence of specific immune reactions.
Current opinion in immunology 1999;11(6):657-62.
1999: Marta E Alarcón-Riquelme; Anna-Karin B Lindqvist; I Jonasson; Bo Johanneson; S Sandino; Jorge Alcocer-Varela; J Granados; H Kristjánsdóttir; Gerdur Gröndal; Elisabet Svenungsson; Ingrid Lundberg; Kristjan Steinsson; Lars Klareskog; Gunnar Sturfelt; Lennart Truedsson; Donato Alarcón-Segovia; Ulf Gyllensten
Genetic analysis of the contribution of IL10 to systemic lupus erythematosus.
The Journal of rheumatology 1999;26(10):2148-52.
1999: Tony Hansson; Göran Annerén; O Sjöberg; Lars Klareskog; Anders Dannaeus
Celiac disease in relation to immunologic serum markers, trace elements, and HLA-DR and DQ antigens in Swedish children with Down syndrome.
Journal of pediatric gastroenterology and nutrition 1999;29(3):286-92.
1999: Gerdur Gröndal; Helga Kristjansdottir; B Gunnlaugsdottir; A Arnason; Ingrid Lundberg; Lars Klareskog; Kristjan Steinsson
Increased number of interleukin-10-producing cells in systemic lupus erythematosus patients and their first-degree relatives and spouses in Icelandic multicase families.
Arthritis and rheumatism 1999;42(8):1649-54.
1999: Bo Johanneson; Kristjan Steinsson; Anna-Karin B Lindqvist; H Kristjánsdóttir; Gerdur Gröndal; S Sandino; Fredrik Tjernström; Gunnar Sturfelt; J Granados-Arriola; Jorge Alcocer-Varela; Ingrid Lundberg; I Jonasson; Lennart Truedsson; Elisabet Svenungsson; Lars Klareskog; Donato Alarcón-Segovia; Ulf Gyllensten; Marta E Alarcón-Riquelme
A comparison of genome-scans performed in multicase families with systemic lupus erythematosus from different population groups.
Journal of autoimmunity 1999;13(1):137-41.
1999: Tony Hansson; Anders Dannaeus; Lars Klareskog
Cytokine-producing cells in peripheral blood of children with coeliac disease secrete cytokines with a type 1 profile.
Clinical and experimental immunology 1999;116(2):246-50.
1999: L Mattsson; Lars Klareskog; Johnny C Lorentzen
Susceptibility of rats to homologous collagen-induced arthritis depends on MHC genes in the class II region.
Transplantation proceedings 1999;31(3):1594-6.
1998: P Larsson; L Mattsson; Lars Klareskog; C Johnsson
A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia.
Clinical and experimental immunology 1998;114(2):277-83.
1998: Johnny C Lorentzen; Anna Glaser; L Jacobsson; J Galli; Hossein Fakhrai-Rad; Lars Klareskog; Holger Luthman
Identification of rat susceptibility loci for adjuvant-oil-induced arthritis.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(11):6383-7.
1998: M Matsuda; Ann-Kristin Ulfgren; Rodica Lenkei; M Petersson; A C Ochoa; Staffan Lindblad; P Andersson; Lars Klareskog; R Kiessling
Decreased expression of signal-transducing CD3 zeta chains in T cells from the joints and peripheral blood of rheumatoid arthritis patients.
Scandinavian journal of immunology 1998;47(3):254-62.
1998: Johan Rönnelid; Louise Berg; Siv Rogberg; A Nilsson; K Albertsson; Lars Klareskog
Production of T-cell cytokines at the single-cell level in patients with inflammatory arthritides: enhanced activity in synovial fluid compared to blood.
British journal of rheumatology 1998;37(1):7-14.
1998: B Sverdrup; Lars Klareskog; Sandra Kleinau
Common commercial cosmetic products induce arthritis in the DA rat.
Environmental health perspectives 1998;106(1):27-32.
1997: E Larsson; A Müssener; D Heinegård; Lars Klareskog; T Saxne
Increased serum levels of cartilage oligomeric matrix protein and bone sialoprotein in rats with collagen arthritis.
British journal of rheumatology 1997;36(12):1258-61.
1997: L Mattsson; Johnny C Lorentzen; Lena Svelander; Anders Bucht; U Nyman; Lars Klareskog; P Larsson
Immunization with alum-collagen II complex suppresses the development of collagen-induced arthritis in rats by deviating the immune response.
Scandinavian journal of immunology 1997;46(6):619-24.
1997: U Nyman; A Müssener; E Larsson; Johnny C Lorentzen; Lars Klareskog
Amelioration of collagen II-induced arthritis in rats by the type IV phosphodiesterase inhibitor Rolipram.
Clinical and experimental immunology 1997;108(3):415-9.
1997: I Lundberg; Ann-Kristin Ulfgren; P Nyberg; Ulf Andersson; Lars Klareskog
Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies.
Arthritis and rheumatism 1997;40(5):865-74.
1997: Johnny C Lorentzen; Lars Klareskog
Comparative susceptibility of DA, LEW, and LEW.1AV1 rats to arthritis induced with different arthritogens: mineral oil, mycobacteria, muramyl dipeptide, avridine and rat collagen type II.
Transplantation proceedings 1997;29(3):1692-3.
1997: Tony Hansson; Anders Dannaeus; Wolfgang Kraaz; O Sjöberg; Lars Klareskog
Production of antibodies to gliadin by peripheral blood lymphocytes in children with celiac disease: the use of an enzyme-linked immunospot technique for screening and follow-up.
Pediatric research 1997;41(4 Pt 1):554-9.
1997: A Müssener; Johnny C Lorentzen; Sandra Kleinau; Lars Klareskog
Altered Th1/Th2 balance associated with non-major histocompatibility complex genes in collagen-induced arthritis in resistant and non-resistant rat strains.
European journal of immunology 1997;27(3):695-9.
1997: A Müssener; M J Litton; E Lindroos; Lars Klareskog
Cytokine production in synovial tissue of mice with collagen-induced arthritis (CIA).
Clinical and experimental immunology 1997;107(3):485-93.
1997: Helena Erlandsson Harris; M Liljeström; Lars Klareskog
Characteristics of synovial fluid effusion in collagen-induced arthritis (CIA) in the DA rat; a comparison of histology and antibody reactivities in an experimental chronic arthritis model and rheumatoid arthritis (RA).
Clinical and experimental immunology 1997;107(3):480-4.
1997: Lars Klareskog
[New perspectives on rheumatoid arthritis].
Läkartidningen 1997;94(1-2):24-7.
1997: Iva Gunnarsson; Johan Rönnelid; Jenny Huang; Siv Rogberg; B Nilsson; Ingrid Lundberg; Lars Klareskog
Association between ongoing anti-C1q antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus.
British journal of rheumatology 1997;36(1):32-7.
1997: A Müssener; K Funa; Sandra Kleinau; Lars Klareskog
Dynamic expression of transforming growth factor-betas (TGF-beta) and their type I and type II receptors in the synovial tissue of arthritic rats.
Clinical and experimental immunology 1997;107(1):112-9.
1996: Johnny C Lorentzen; Lars Klareskog
Susceptibility of DA rats to arthritis induced with adjuvant oil or rat collagen is determined by genes both within and outside the major histocompatibility complex.
Scandinavian journal of immunology 1996;44(6):592-8.
1996: Per Hellman; A Karlsson-Parra; Lars Klareskog; Peter Ridefelt; G Bjerneroth; Jonas Rastad; Göran Akerström; Claes Juhlin
Expression and function of a CD4-like molecule in parathyroid tissue.
Surgery 1996;120(6):985-92.
1995: Johnny C Lorentzen; S Issazadeh; Maria K Storch; M I Mustafa; H Lassman; Christopher Linington; Lars Klareskog; Tomas Olsson
Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant.
Journal of neuroimmunology 1995;63(2):193-205.
1995: Per Hellman; Claes Juhlin; A Karlsson-Parra; Lars Klareskog; Peter Ridefelt; Jonas Rastad; Göran Akerström
Expression and function of a CD3-like molecule on normal and abnormal human parathyroid cells.
Surgery 1995;118(6):1055-61; discussion 1062.
1995: Lars Klareskog; Johan Rönnelid; G Holm
Immunopathogenesis and immunotherapy in rheumatoid arthritis: an area in transition.
Journal of internal medicine 1995;238(3):191-206.
1995: Ann-Kristin Ulfgren; Staffan Lindblad; Lars Klareskog; J Andersson; U Andersson
Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis.
Annals of the rheumatic diseases 1995;54(8):654-61.
1995: H Erlandsson; A Müssener; Lars Klareskog; D P Gold
Restricted T-cell receptor usage in DA rats during early collagen-induced arthritis.
Annals of the New York Academy of Sciences 1995;756():225-6.
1995: A Müssener; Lars Klareskog; Johnny C Lorentzen; Sandra Kleinau
TNF-alpha dominates cytokine mRNA expression in lymphoid tissues of rats developing collagen- and oil-induced arthritis.
Scandinavian journal of immunology 1995;42(1):128-34.
1995: Johnny C Lorentzen; H Erlandsson; A Müssener; L Mattsson; Sandra Kleinau; U Nyman; Lars Klareskog
Specific and long-lasting protection from collagen-induced arthritis and oil-induced arthritis in DA rats by administration of immunogens.
Scandinavian journal of immunology 1995;42(1):82-9.
1995: Sandra Kleinau; L Dencker; Lars Klareskog
Oil-induced arthritis in DA rats: tissue distribution of arthritogenic 14C-labelled hexadecane.
International journal of immunopharmacology 1995;17(5):393-401.
1995: Johnny C Lorentzen; T Olsson; Lars Klareskog
Susceptibility to oil-induced arthritis in the DA rat is determined by MHC and non-MHC genes.
Transplantation proceedings 1995;27(2):1532-4.
1995: Johan Rönnelid; Lars Klareskog
Local versus systemic immunoreactivity to collagen and the collage-like region of C1q in rheumatoid arthritis and SLE.
Scandinavian journal of rheumatology. Supplement 1995;101():57-61.
1995: Sandra Kleinau; J Lorentzen; Lars Klareskog
Role of adjuvants in turning autoimmunity into autoimmune disease.
Scandinavian journal of rheumatology. Supplement 1995;101():179-81.
1994: J Björk; Sandra Kleinau; T Midtvedt; Lars Klareskog; G Smedegård
Role of the bowel flora for development of immunity to hsp 65 and arthritis in three experimental models.
Scandinavian journal of immunology 1994;40(6):648-52.
1994: H Erlandsson; A Müssener; Lars Klareskog; D P Gold
Restricted T cell receptor usage in DA rats during early collagen-induced arthritis.
European journal of immunology 1994;24(8):1929-32.
1994: Johan Rönnelid; Jenny Huang; T Norrlander; Siv Rogberg; B Nilsson; R Gustafsson; Lars Klareskog
Short-term kinetics of the humoral anti-C1q response in SLE using the ELISPOT method: fast decline in production in response to steroids.
Scandinavian journal of immunology 1994;40(2):243-50.
1994: J Rönnelid; J Lysholm; A Engström-Laurent; Lars Klareskog; B Heyman
Local anti-type II collagen antibody production in rheumatoid arthritis synovial fluid. Evidence for an HLA-DR4-restricted IgG response.
Arthritis and rheumatism 1994;37(7):1023-9.
1994: Sandra Kleinau; H Erlandsson; Lars Klareskog
Percutaneous exposure of adjuvant oil causes arthritis in DA rats.
Clinical and experimental immunology 1994;96(2):281-4.
1994: Per Hellman; J Albert; Magnus Gidlund; Lars Klareskog; Jonas Rastad; Göran Akerström; Claes Juhlin
Impaired parathyroid hormone release in human immunodeficiency virus infection.
AIDS research and human retroviruses 1994;10(4):391-4.
1993: G Bjerneroth; Claes Juhlin; Jonas Rastad; Göran Akerström; Lars Klareskog
MHC class I and II antigen expression on parathyroid cells and prospects for their allogenic transplantation.
Transplantation 1993;56(3):717-21.
1993: Birgitta Heyman; Sven Gustavsson; C Kusakari; M Nose; T Kinoshita; Lars Klareskog; A Tarkowski
Antibody feedback regulation in MRL/lpr mice.
Journal of autoimmunity 1993;6(4):437-48.
1993: Sandra Kleinau; Lars Klareskog
Oil-induced arthritis in DA rats passive transfer by T cells but not with serum.
Journal of autoimmunity 1993;6(4):449-58.
1992: S Gudmundsson; J Rönnelid; A Karlsson-Parra; J Lysholm; B Gudbjörnsson; B Widenfalk; C H Janson; Lars Klareskog
T-cell receptor V-gene usage in synovial fluid and synovial tissue from RA patients.
Scandinavian journal of immunology 1992;36(5):681-8.
1992: C Nordling; Sandra Kleinau; Lars Klareskog
Down-regulation of a spontaneous arthritis in male DBA/1 mice after administration of monoclonal anti-idiotypic antibodies to a cross-reactive idiotope on anti-collagen antibodies.
Immunology 1992;77(1):144-6.
1992: G A Edelstam; O E Lundkvist; Lars Klareskog; A Karlsson-Parra
Cyclic variation of major histocompatibility complex class II antigen expression in the human fallopian tube epithelium.
Fertility and sterility 1992;57(6):1225-9.
1992: C Nordling; A Karlsson-Parra; L Jansson; Rikard Holmdahl; Lars Klareskog
Characterization of a spontaneously occurring arthritis in male DBA/1 mice.
Arthritis and rheumatism 1992;35(6):717-22.
1992: A F Wells; Lars Klareskog; S Lindblad; T C Laurent
Correlation between increased hyaluronan localized in arthritic synovium and the presence of proliferating cells. A role for macrophage-derived factors.
Arthritis and rheumatism 1992;35(4):391-6.
1992: A Wanders; A F Wells; Gunnar Tufveson; Lars Klareskog
Gamma-interferon-like substance is expressed in myocytes of cardiac allografted rats treated with cyclosporine A.
Transplantation proceedings 1992;24(1):346.
1992: Anders Bucht; J R Oksenberg; S Lindblad; A Grönberg; L Steinman; Lars Klareskog
Characterization of T-cell receptor alpha beta repertoire in synovial tissue from different temporal phases of rheumatoid arthritis.
Scandinavian journal of immunology 1992;35(2):159-65.
1992: A Wanders; A F Wells; E Larsson; Gunnar Tufveson; T Olsson; A Ljungdahl; Lars Klareskog
Expression of an interferon-gamma-like substance in normal and transplanted rat heart tissue.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1992;11(1 Pt 1):142-6.
1991: Sandra Kleinau; H Erlandsson; Rikard Holmdahl; Lars Klareskog
Adjuvant oils induce arthritis in the DA rat. I. Characterization of the disease and evidence for an immunological involvement.
Journal of autoimmunity 1991;4(6):871-80.
1991: Lars Klareskog; J Rönnelid; S Gudmundsson; A Karlsson-Parra
Rheumatoid arthritis.
Current opinion in immunology 1991;3(6):912-6.
1991: C Nordling; Rikard Holmdahl; Lars Klareskog
A monoclonal antiidiotypic antibody with rheumatoid factor activity defines a cross-reactive idiotope on murine anticollagen antibodies.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(12):4258-63.
1991: Rolf Kiessling; A Grönberg; J Ivanyi; K Söderström; M Ferm; Sandra Kleinau; E Nilsson; Lars Klareskog
Role of hsp60 during autoimmune and bacterial inflammation.
Immunological reviews 1991;121():91-111.
1991: Nils Feltelius; S Gudmundsson; L Wennersten; O Sjöberg; Roger Hällgren; Lars Klareskog
Enumeration of IgA producing cells by the enzyme linked immunospot (ELISPOT) technique to evaluate sulphasalazine effects in inflammatory arthritides.
Annals of the rheumatic diseases 1991;50(6):369-71.
1991: C Nordling; Rikard Holmdahl; Lars Klareskog
Down-regulation of collagen arthritis after in vivo treatment with a syngeneic monoclonal anti-idiotypic antibody to a cross-reactive idiotope on collagen II auto-antibodies.
Immunology 1991;72(4):486-90.
1991: Sandra Kleinau; K Söderström; Rolf Kiessling; Lars Klareskog
A monoclonal antibody to the mycobacterial 65 kDa heat shock protein (ML 30) binds to cells in normal and arthritic joints of rats.
Scandinavian journal of immunology 1991;33(2):195-202.
1991: Lars Klareskog
Antigen presentation in joints in the pathogenesis of arthritis.
British journal of rheumatology 1991;30 Suppl 1():53-7.
1990: Lars Klareskog; T Olsson
Autoimmunity to collagen II and myelin basic protein: comparative studies in humans and rodents.
Immunological reviews 1990;118():285-310.
1990: A F Wells; E Larsson; A Tengblad; Bengt Fellström; Gunnar Tufveson; Lars Klareskog; T C Laurent
The localization of hyaluronan in normal and rejected human kidneys.
Transplantation 1990;50(2):240-3.
1990: A Karlsson-Parra; Pia Burman; H Hagberg; Kjell Oberg; Gunnar V Alm; Lars Klareskog; F Anders Karlsson
Autoantibodies to epithelial cells in patients on long-term therapy with leucocyte-derived interferon-alpha (IFN-alpha).
Clinical and experimental immunology 1990;81(1):72-5.
1990: A Karlsson-Parra; K Söderström; M Ferm; J Ivanyi; Rolf Kiessling; Lars Klareskog
Presence of human 65 kD heat shock protein (hsp) in inflamed joints and subcutaneous nodules of RA patients.
Scandinavian journal of immunology 1990;31(6):283-8.
1990: P Larsson; Sandra Kleinau; Rikard Holmdahl; Lars Klareskog
Homologous type II collagen-induced arthritis in rats. Characterization of the disease and demonstration of clinically distinct forms of arthritis in two strains of rats after immunization with the same collagen preparation.
Arthritis and rheumatism 1990;33(5):693-701.
1990: Erik Gylfe; Claes Juhlin; Göran Akerström; Lars Klareskog; L Rask; Jonas Rastad
Monoclonal antiparathyroid antibodies--tools for studies of the regulation of cytoplasmic calcium and function of parathyroid and other antibody-reactive cells.
Cell calcium 1990;11(5):329-32.
1989: Bengt Fellström; Lars Klareskog; Carl-Henrik Heldin; E Larsson; L Rönnstrand; Louis Terracio; Gunnar Tufveson; J Wahlberg; Kristofer Rubin
Platelet-derived growth factor receptors in the kidney--upregulated expression in inflammation.
Kidney international 1989;36(6):1099-102.
1989: A Karlsson-Parra; E Dimény; Claes Juhlin; Bengt Fellström; Lars Klareskog
The anti-Leu4 (CD3) monoclonal antibody reacts with proximal tubular cells of the human kidney.
Scandinavian journal of immunology 1989;30(6):719-22.
1989: P Larsson; T J Goldschmidt; Lars Klareskog; Rikard Holmdahl
Oestrogen-mediated suppression of collagen-induced arthritis in rats. Studies on the role of the thymus and of peripheral CD8+ T lymphocytes.
Scandinavian journal of immunology 1989;30(6):741-7.
1989: Sandra Kleinau; P Larsson; J Björk; Rikard Holmdahl; Lars Klareskog
Linomide, a new immunomodulatory drug, shows different effects on homologous versus heterologous collagen-induced arthritis in rats.
Clinical and experimental immunology 1989;78(1):138-42.
1989: Andrej Tarkowski; Lars Klareskog; Hans Carlsten; P Herberts; W J Koopman
Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis.
Arthritis and rheumatism 1989;32(9):1087-92.
1989: Rikard Holmdahl; J Mo; C Nordling; P Larsson; L Jansson; T Goldschmidt; M Andersson; Lars Klareskog
Collagen induced arthritis: an experimental model for rheumatoid arthritis with involvement of both DTH and immune complex mediated mechanisms.
Clinical and experimental rheumatology 1989;7 Suppl 3():S51-5.
1989: Claes Juhlin; Jonas Rastad; Lars Klareskog; Lars Grimelius; Göran Akerström
Parathyroid histology and cytology with monoclonal antibodies recognizing a calcium sensor of parathyroid cells.
The American journal of pathology 1989;135(2):321-8.
1989: P Larsson; Rikard Holmdahl; Lars Klareskog
In vivo treatment with anti-CD8 and anti-CD5 monoclonal antibodies alters induced tolerance to adjuvant arthritis.
Journal of cellular biochemistry 1989;40(1):49-56.
1989: A Karlsson-Parra; E Dimény; Bengt Fellström; Lars Klareskog
HIV receptors (CD4 antigen) in normal human glomerular cells.
The New England journal of medicine 1989;320(11):741.
1989: Rikard Holmdahl; C Bailey; I Enander; R Mayer; Lars Klareskog; T Moran; C Bona
Origin of the autoreactive anti-type II collagen response. II. Specificities, antibody isotypes and usage of V gene families of anti-type II collagen B cells.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(6):1881-6.
1989: P Allebeck; H O Adami; Lars Klareskog; I Persson
Non-contraceptive hormones and rheumatoid arthritis: possibilities of using a Swedish population-based cohort.
British journal of rheumatology 1989;28 Suppl 1():38-40; discussion 42-5.
1989: Lars Klareskog
What can we learn about rheumatoid arthritis from animal models?
Springer seminars in immunopathology 1989;11(3):315-33.
1989: Andrej Tarkowski; R Holmdahl; Lars Klareskog
Rheumatoid factors in mice.
Monographs in allergy 1989;26():214-29.
1988: N J Mauritz; Rikard Holmdahl; R Jonsson; P H Van der Meide; A Scheynius; Lars Klareskog
Treatment with gamma-interferon triggers the onset of collagen arthritis in mice.
Arthritis and rheumatism 1988;31(10):1297-304.
1988: Rikard Holmdahl; M Andersson; I Enander; T Goldschmidt; L Jansson; P Larsson; J Mo; C Nordling; Lars Klareskog
Nature of the type II collagen autoimmunity in mice susceptible to collagen-induced arthritis.
International reviews of immunology 1988;4(1):49-64.
1988: T J Goldschmidt; Rikard Holmdahl; Lars Klareskog
Depletion of murine T cells by in vivo monoclonal antibody treatment is enhanced by adding an autologous anti-rat kappa chain antibody.
Journal of immunological methods 1988;111(2):219-26.
1988: A Karlsson-Parra; M Kobbah; Uwe Ewald; Torsten Tuvemo; U Forsum; Lars Klareskog
Circulating class II transplantation antigen-expressing T lymphocytes in children with insulin-dependent diabetes mellitus at diagnosis.
Acta paediatrica Scandinavica 1988;77(4):554-8.
1988: Kristofer Rubin; A Tingström; G K Hansson; E Larsson; L Rönnstrand; Lars Klareskog; Lena Claesson-Welsh; Carl-Henrik Heldin; Bengt Fellström; Louis Terracio
Induction of B-type receptors for platelet-derived growth factor in vascular inflammation: possible implications for development of vascular proliferative lesions.
Lancet 1988;1(8599):1353-6.
1988: K Claesson; L Mjörnstedt; Lars Klareskog; E Larsson; M Olausson; T Söderström; H Brynger; Gunnar Tufveson
Morphologic and immunohistochemical changes in antithymocyte globulin-induced permanently surviving rat cardiac allografts.
Transplantation proceedings 1988;20(3):523-4.
1988: Claes Juhlin; Lars Klareskog; P Nygren; Sverker Ljunghall; Erik Gylfe; Jonas Rastad; Göran Akerström
Hyperparathyroidism is associated with reduced expression of a parathyroid calcium receptor mechanism defined by monoclonal antiparathyroid antibodies.
Endocrinology 1988;122(6):2999-3001.
1988: Cecil Czerkinsky; G Andersson; H P Ekre; LA Nilsson; Lars Klareskog; O Ouchterlony
Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells.
Journal of immunological methods 1988;110(1):29-36.
1988: Andrej Tarkowski; Roland Jonsson; R Sanchez; Lars Klareskog; W J Koopman
Features of renal vasculitis in autoimmune MRL lpr/lpr mice: phenotypes and functional properties of infiltrating cells.
Clinical and experimental immunology 1988;72(1):91-7.
1988: Kristofer Rubin; Louis Terracio; L Rönnstrand; Carl-Henrik Heldin; Lars Klareskog
Expression of platelet-derived growth factor receptors is induced on connective tissue cells during chronic synovial inflammation.
Scandinavian journal of immunology 1988;27(3):285-94.
1988: K Claesson; L Mjörnstedt; Lars Klareskog; E Larsson; M Olausson; T Söderström
Morphology of rat cardiac allografts with permanent survival induced by antithymocyte globulin.
Scandinavian journal of immunology 1988;27(2):171-9.
1988: Rikard Holmdahl; R Jonsson; P Larsson; Lars Klareskog
Early appearance of activated CD4+ T lymphocytes and class II antigen-expressing cells in joints of DBA/1 mice immunized with type II collagen.
Laboratory investigation; a journal of technical methods and pathology 1988;58(1):53-60.
1988: C Nordling; Lars Klareskog
Interactions between the immune system and connective tissue in arthritis. Possible significance of an affinity between IgG and native type II collagen.
Scandinavian journal of rheumatology. Supplement 1988;74():73-8.
1988: Lars Klareskog; O Johnell
Induced expression of class II transplantation antigens in the cartilage-pannus junction in RA: chronic synovitis as a model system for aberrant T-lymphocyte activation.
British journal of rheumatology 1988;27 Suppl 2():141-9.
1988: S Gudmundsson; O Sjöberg; Lars Klareskog
Interactions between the immune system and connective tissue in arthritis: aspects on T-cell activation.
Scandinavian journal of rheumatology. Supplement 1988;76():117-24.
1987: Rikard Holmdahl; L Jansson; B Meyerson; Lars Klareskog
Oestrogen induced suppression of collagen arthritis: I. Long term oestradiol treatment of DBA/1 mice reduces severity and incidence of arthritis and decreases the anti type II collagen immune response.
Clinical and experimental immunology 1987;70(2):372-8.
1987: Roland Jonsson; Lars Klareskog; K Bäckman; Andrej Tarkowski
Expression of HLA-D-locus (DP, DQ, DR)-coded antigens, beta 2-microglobulin, and the interleukin 2 receptor in Sjögren's syndrome.
Clinical immunology and immunopathology 1987;45(2):235-43.
1987: Rikard Holmdahl; A Tarkowski; C Nordling; Kristofer Rubin; Lars Klareskog
Connection between autoimmunity to cartilage type II collagen and rheumatoid factor production.
Monographs in allergy 1987;22():71-80.
1987: Lars Klareskog; Rikard Holmdahl; T Goldschmidt; J Björk
Immunoregulation in arthritis. A review on synovial immune reactions in RA and in some experimental animal models for arthritis.
Scandinavian journal of rheumatology. Supplement 1987;64():7-15.
1987: Lars Klareskog; Rikard Holmdahl; C Nordling; A Tarkowski; Kristofer Rubin
Synovial class II antigen expression and immune complex formation in rheumatoid arthritis.
Acta medica Scandinavica. Supplementum 1987;715():85-91.
1986: Rikard Holmdahl; Lars Klareskog; K Rubin; J Björk; G Smedegård; R Jonsson; M Andersson
Role of T lymphocytes in murine collagen induced arthritis.
Agents and actions 1986;19(5-6):295-305.
1986: Rikard Holmdahl; C Nordling; Kristofer Rubin; A Tarkowski; Lars Klareskog
Generation of monoclonal rheumatoid factors after immunization with collagen II-anti-collagen II immune complexes. An anti-idiotypic antibody to anti-collagen II is also a rheumatoid factor.
Scandinavian journal of immunology 1986;24(2):197-203.